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Abstract 
 
Tissue engineering involves the use of cells, growth factors/cytokines, and scaffolds to 
regenerate damaged tissue.  The choice of cells, scaffold and their delivery is crucial to 
the successful outcome of the treatment and this is particularly the case in bone and 
cartilage where the repair tissue has to recreate a structural hierarchy to restore long 
lasting function. One approach to deliver high numbers of cells to a defect site is as cell 
aggregates or spheroids.  Experiments are described here that aim to understand how 
mesenchymal stem cells (MSCs) and osteoblastic cells behave in a cell aggregate and 
how this could be refined by the inclusion a self -assembling hydrogel to influence cell-
cell and cell-extracellular matrix (ECM) interactions. Forming cellular spheroids in vitro 
can be achieved using various methods, including hanging drop, static suspension culture, 
encapsulation/entrapment, and low adherence multi-well.  Extensive analysis identified 
that the most efficient and reproducible method for the formation of spheroids using rat 
osteoblasts and human MSCs was through their culture at a specific concentration in 
polyHEMA coated plates.  Both viability and ability of cells to differentiate was 
investigated.  The MTT assay was used to assess cells viability while their ability to 
differentiate was assessed by measuring alkaline phosphatase activity as well as 
measuring gene osteogenic markers expression via qRT-PCR.  Analysis of cell 
differentiation under these conditions revealed that alkaline phosphatase activity appeared 
more elevated in 2D cultures compared to 3D.  However, it was noted that there were 
contrasting results between the two types of cells with expression of osteogenic genes 
higher when MSCs were grown in osteogenic media while with calvarial significant 
expression was also observed when grown in normal media.  Because of the distinct 
regulatory cues given by cell-cell contact in the spheroid, analysis was performed for 
connexin (Cx)-43, a gap junction protein and members of the ephrin/Eph family.  Cx-43 
 
iv 
was immunolocalised to gap junction structures in cells after osteogenic treatment on a 
flat substrate but this was more difficult to assess in the 3D spheroids. Analysis of 
transcript patterns reflected the increased abundance of Cx-43 in cells treated with 
osteogenic supplements and parallel changes in expression of Ephrin B1 and Ephrin B2.  
Experiments were also performed including a Puramatrix hydrogel nanofibers scaffold 
that could encase the cells in an ECM-like environment, provide mechanical support and 
protect them and manipulate cell-cell interactions. The results obtained in this study 
concluded that calvaria cells viability and hence proliferation increased when grown 
embedded within 0.25% Puramtrix while mesenchymal stem cells increased when 
embedded in 0.5% Puramatrix. Similarly, alkaline phosphatase activity was higher in 
cells embedded within 0.25% Puramatrix while mesenchymal stem cells favoured 0.5%. 
On the other hand, osteogenic gene expression of both cells was enhanced with the use of 
Puramatrix scaffold.  
 
 
 
 
 
v 
 
List of abbreviations 
 
BMPs Bone Morphogenetic Proteins 
DAPI 4',6-diamidino-2-phenylindole 
DEPC  Diethylpyrocarbonate 
DMEM Dulbecco's modified Eagle's medium 
dNTPs Deoxynucleotidetriphosphates 
DPBS Dulbecco s Phosphate Buffered Saline 
DTT Dithiothreitol 
EBs Embryoid bodies  
ECM Extracellular matrix 
ESs Embryonic stem cells 
FBS Fetal bovine serum 
GPI Glycosylphosphatidylinisotol 
MCP-1 Monocyte chemoattractant protein 1 
MSCs Mesenchymal stem cells  
PCR polymerase chain reaction 
Poly-HEMA Poly (2-hydroxyethyl methacrylate) 
qRT-PCR Quantitative reverse transcription polymerase chain reaction  
SDF-1 Stromal cell-derived factor-1 
SDS Sodium dodecyl sulfate 
TAE Tris-acetate-EDTA 
 
 
vi 
 
List of tables 
 
 
Table 1.1: Natural and synthetic materials available to be used as scaffolds……… 3 
Table 1.2: Parameters to optimize biomaterials for tissue regeneration…………… 5 
Table 1.3: Eph receptors and ephrin ligands specifities arranged depending on their 
affinity…………………………………………………………………..………….. 
19 
Table 2.1: thermal cycles for genes amplification………………………….………. 31 
Table 2.2: list of rat primers used for qRT-PCR analysis…………………………….. 32 
Table 2.3: list of human primers used for qRT-PCR analysis……………….………. 33 
 
 
vii 
 
List of figures 
 
Figure 1.1: Tissue engineering three key elements ……………………………….. 1 
Figure 1.2: A mummy skull with a golden plate used to repair a defect at the front 
of the skull…………………………………………………………………………. 
2 
Figure 1.3: An amputated toe replaced with a wooden one……………………….. 2 
Figure 1.4: Examples of different structures of self -assembled peptides…………. 6 
Figure 1.5:   Puramatrix molecular model………………………………………… 8 
Figure 1.6:   (A) self-assembled Puramatrix 1%    (B) Puramatrix SEM image 
shows the formation of nanofibers (10-20 nm) …………………………………… 
8 
Figure 1.7.: Molecular model of  DAR 16-IV…………………………................. 9 
Figure 1.8: (A) cells grown in a designed pattern coated with molecular carpet 
peptides (B) Molecular model of RADSC-14 which forms a monolayer on surface 
and attract specific molecules……………………………………………………… 
10 
Figure 1.9: 3D culture methods……………..……………………………………… 11 
Figure 1.10: 3D culture methods……………..…………………………………… 14 
Figure 1.11: Bone remodeling three phases which involves bone resorption and 
formation………………………………………………………………………….. 
15 
Figure 1.12: Osteoclast – osteoblast interaction in bone remodelling……………… 16 
Figure 1.13: Eph receptors and ephrin ligands structure…………………………… 18 
Figure 1.14: Eph/ephrin signaling in bone homeostasis……………….…………... 20 
Figure 2.1: Illustration of a hemocytometer slide…………………………………. 23 
Figure 2.2: Represents the chemical structure of MTT and its reduction by 
mitochondrial enzymes in viable cells to formazan……………….......................... 
25 
Figure 2.3: Represents the chemical structure of a p-nitrophenol molecule ……... 26 
 
viii 
Figure 2.4: drawing of RNA extraction steps  ……………………………………. 28 
Figure  2.5: Measuring RNA using Nanodrop instrument ………………………… 29 
Figure 2.6: Cell block preparation with a collodion bag…………………………… 35 
Figure 2.7: Schematic of direct and indirect Immunofluorescence methods……..... 36 
Figure 3.1: 3D optimization plan…………………………………………………… 39 
Figure 3.2: Shows an uneven polyHEMA coating that led to cells attaching in 
some areas, while some formed spheres…………………………………………… 
46 
Figure 3.3: Calvarial cells grown on the surface of a 96u rounded bottom plate ….. 47 
Figure 3.4: Low density of calvarial cells grown on the surface of a 96u rounded 
bottom plate at 7days …………………………………………………………… 
47 
Figure 3.5: Calvarial cells grown under osteogenic conditions on the surface of a 
96u rounded bottom plate at day 14 ……………………………………………… 
48 
Figure 3.6: Calvarial cells grown under osteogenic conditions on the surface of a 
96u rounded bottom plate at day 21 …………………………………………… 
48 
Figure 3.7: Calvarial cells grown on the surface of a 24 well in a serum free media 
after 24hr ………………………………………………………………………… 
49 
Figure 3.8: High densities of calvarial cells grown on the surface of a 24 well in a 
serum free media at 7days ………………………………………………………… 
49 
Figure 3.9: Calvarial cells grown on the surface of a 24 well in a serum free media 
at 14days under osteogenic conditions …………………………………………… 
50 
Figure 3.10: Calvarial cells grown using hanging drop technique after 24hr …….. 50 
 
ix 
Figure 3.11: Calvarial cells grown after 48hr using hanging drop technique ……… 51 
Figure 3.12: Calvarial cells grown at 21days using hanging drop technique ……… 52 
Figure 3.13: Calvarial cells grown after 24hrin normal media mixed with 
methylcellulose ……………………………………………………………………. 
52 
Figure 3.14: Calvarial cells at 21days grown in osteogenic media mixed with 
methylcellulose ……………………………………………………………………. 
53 
Figure 3.15: Calvarial cells grown after 48hr on the surface of 24 well plate coated 
with polyHEMA …………………………………………………………………. 
53 
Figure 3.16: Calvarial cells grown on the surface of a 24 well plate coated with 
polyHEMA after 14days …………………………………………………………… 
54 
Figure 3.17: Shows the surface of high concentration [40mg/ml] polyHEMA 
coating which was broken after 14 days ………………………………………… 
54 
Figure 3.18: Calvarial cells grown after 24hr on the surface of 24 well plate coated 
with 2% agar …………………………………………………………………….… 
55 
Figure 3.19: Calvarial cells grown after 24hr on the surface of 24 well plate coated 
with 0.5% agar …………………………………………………………….…….… 
55 
Figure 3.20: Calvarial cells grown after 14 days shows the formation of large 
spheroid by time at high cells density ………………………………………… 
56 
Figure 3.21: Calvarial cells grown after 14 days shows cells suspended in the 
media while most of the cells attached to the surface of the well…………..………. 
56 
  
 
x 
Figure 3.22: shows MTT Viability assay results for cells grown in normal media 
with cell density approximately 14 x10
6
 …………………………………………… 
60 
Figure 3.23: shows MTT Viability assay results for cells grown in osteogenic 
media with cell density approximately 14 x10
5………………………………....... 
61 
Figure 3.24: shows MTT Viability assay results for cells grown in normal media 
with cell density approximately 6 x10
5…………………………………….............. 
62 
Figure 3.25: is a graph that represents MTT Viability assay results for cells grown 
in osteogenic media with cell density approximately 6 x10
5
 .the vertical axis 
represents absorbance while horizontal axis represents time. …………................... 
63 
Figure 3.26: shows MTT Viability assay results for cells grown in normal media 
with cell density approximately 3.5 x10
5…………………....................................... 
64 
Figure 3.27: shows MTT Viability assay results for cells grown in osteogenic 
media with cell density approximately 3.5 x10
5……………………………………. 
65 
Figure 3.28: shows MTT Viability assay results for cells grown in normal media 
with cell density approximately 0.5 x10
5………………………………………….. 
66 
Figure 3.29: shows MTT Viability assay results for cells grown in osteogenic 
media with cell density approximately 0.5 x10
5…………………………............... 
67 
Figure 3.30: shows (a)  spheroids generation on plates coated with poly-HEMA (b) 
Spheroids diameter measurement ……………………………………….…………. 
69 
Figure 3.31: Data represents the mean ± standard error of the mean statistical 
significant determined using Kruskal-Wallis test. P value ≤ 0.05 was considered 
significant (a) number of spheroids. (b) Spheroids diameter ……………………… 
70 
 
xi 
Figure 4.1: Immunofluorescent staining of Cx43 in rat calverial cells monolayers 
grown for 7 days under normal conditions. Cx43 [green] localize around the 
nucleus [blue] and at the cell membrane ………………………………………..... 
82 
Figure 4.2: Immunofluroescent staining of Cx43 in rat calverial cells monolayers 
grown for 7 days under osteogenic conditions. Cx43 [green] localize at the cell 
membrane ……………………………………………………………………….. 
83 
Figure 4.3: Immunofluorescent staining of Cx43 in rat calvarial cells 3D grown for 
7 days (a) Normal media (b) osteogenic media. Cx43 [green] while nucleus is 
stained with DAPI [blue]………………………………………………………….. 
84 
Figure 4.4: Immunofluorescent staining of Cx43 in human mesenchymal stem 
cells 3D grown for 7 days (a) Normal media (b) osteogenic media. Cx43 [green] 
while nucleus is stained with DAPI [blue]………………………………………... 
85 
Figure 4.5: laser confocal images of Cx43 in rat calvarial cells 3D grown for 7 
days (a) Normal media (b) osteogenic media. Cx43 [green] while nucleus is 
stained with DAPI [blue]…………………………………………………..……… 
86 
Figure 4.6: laser confocal images of Cx43 in human mesenchymal stem cells 3D 
grown for 7 days (a) Normal media (b) osteogenic media. Cx43 [green] while 
nucleus is stained with DAPI [blue]………………………………………………. 
87 
Figure 4.7: laser confocal microscopy series images of a spheroid. Cx43 [green] 
while nucleus is stained with DAPI [blue]…………………………………............. 
88 
Figure 4.8: a Z -section confocal microscope image of spheroids with a thickness 
(a) 52.2µm and (b) 97.49µm …………………………………….............................. 
89 
Figure 4.9: spheroid section stained with H&E (a) lower and (b) higher 90 
 
xii 
magnification………………………………………………………………………. 
Figure 4.10: spheroid section stained withantiCx43 antibody (a) nucleus stained 
blue using DAPI (b) Cx43……………………………………................................. 
91 
Figure 4.11:  SEM image of rat calvarial cells spheroids pellet (a) normal media 
(b) osteogenic media ………………………………………................................... 
93 
Figure 4.12:  SEM image of rat calvarial cells spheroids after 24hr grown in 
normal media (a) lower magnification (b) and (c) higher magnification illustrates 
communication between spheroids ………………………………………………… 
94 
Figure 4.13:  SEM image of rat calvarial cells spheroids after 24hr grown in 
osteogenic media (a) lower and (b) higher magnification illustrates small spheres 
in contact with a larger sphere……………………………………………………… 
95 
Figure 4.14:  SEM image of rat calvarial cells spheroids at 7days grown in normal 
media (a) lower and (b) higher magnification illustrates a compact 
sphere……………………………………………………………………………….. 
96 
Figure 4.15:  SEM image of rat calvarial cells spheroids at 7days grown in 
osteogenic media (a) lower and (b) higher magnification illustrates spheres that 
dissociate …………………………………………………………….…………….. 
97 
Figure 4.16:  SEM image of human mesenchymal stem cells spheroids after 24hr 
grown in (a) normal media and (b) osteogenic media……………………………... 
98 
Figure 4.17:  SEM image of human mesenchymal stem cells spheroids at 7days 
grown in (a) normal media and (b) osteogenic media…………………………...... 
99 
Figure 4.18:  SEM image of spheroids with amorphous coating believed to be 100 
 
xiii 
polyHEMA from the surface of the culture plates ………………………............... 
Figure 4.19 Graph shows the viability of calvarial rat cells after 24hr………….. 102 
Figure 4.20 Graph shows the viability of human MSCs after 24hr………………. 102 
Figure 4.21 Graph shows the viability of rat calvarial cells at 72hr……………….. 103 
Figure 4.22 Graph shows the viability of human MSCs at 72hr…………………..... 103 
Figure 4.23 Graph shows the viability of rat calvarial cells at 7days…………….… 104 
Figure 4.24 Graph shows the viability of human MSCs at 7days.……………… 104 
Figure 4.25 Graph shows the alkaline phosphatase activity level of rat calverial 
cells after 24hr…......................................................................................................... 
106 
Figure 4.26 Graph shows the alkaline phosphatase activity level of human MSCs 
after 24hr ………………………………………………………..……………….. 
106 
Figure 4.27 Graph shows the alkaline phosphatase activity level of rat calverial 
cells at 72hr……......................................................................................................... 
107 
Figure 4.28 Graph shows the alkaline phosphatase activity level of human MSCs 
at 72hr……………………………………………………………………............. 
107 
Figure 4.29 Graph shows the alkaline phosphatase activity level of rat calverial 
cells at 7days……………………………………………………………..……...... 
108 
Figure 4.30 Graph shows the alkaline phosphatase activity level of human MSCs 
at 7days………………………................................................................................... 
108 
Figure 4.31 ALP relative level expression in rat calvarial cells after 24hr ………… 110 
 
xiv 
Figure 4.32 ALP relative level expression in MSCs after 24hr  ………………….. 110 
Figure 4.33 ALP relative level expression in rat calvarial cells at 72hr, the data 
represents the mean ± standard error of the mean, a statistical significant was 
considered when P value ≤ 0.05…………………………………………………….  
111 
Figure 4.34 ALP relative level MSCs at 72hr………………………………………. 111 
Figure 4.35 ALP relative level Rat cells at 7days…………………………………. 112 
Figure 4.36 ALP relative level MSCs cells at 7days…………............................….. 112 
Figure 4.37 RUNX 2 relative level expression in rat cells after 24hr………………. 114 
Figure 4.38 RUNX 2 relative level expression in MSCs after 24hr……………..…. 114 
Figure 4.39 RUNX 2 relative level expression in rat cells at 72hr………….….… 115 
Figure 4.40 RUNX 2 relative level expression in MSCs at 72hr……………….… 115 
Figure 4.41 RUNX 2 relative level expression in rat cells at 7days………….…… 116 
Figure 4.42 RUNX 2 relative level expression in MSCs at 7days……………….… 116 
Figure 4.43 SP7 relative level expression in rat cells after 24hr…………..….…… 118 
Figure 4.44 SP7 relative level expression in MSCs after 24hr…………...………… 118 
Figure 4.45 SP7 relative level expression in rat cells at 72hr…………...………….. 119 
Figure 4.46 SP7 relative level expression in MSCs at 72hr………………………… 119 
Figure 4.47 SP7 relative level expression in Rat cells at 7days……………….…… 120 
Figure 4.48 SP7 relative level expression in MSCs at 7days …………………….… 120 
 
xv 
Figure 4.49 CX43 relative level expression in rat cells after 24hr ……………….. 122 
Figure 4.50 CX43 relative level expression in MSCs after 24hr…………………... 122 
Figure 4.51 CX43 relative level expression in rat cells at 72hr………………….… 123 
Figure 4.52 CX43 relative level expression in MSCs at 72hr……………………… 123 
Figure 4.53 CX43 relative level expression in rat calvarial cells at 7days…..…..….  124 
Figure 4.54 CX43 relative level expression in MSCs at 7days…………….…….. 124 
Figure 4.55 Ephrin B1 relative level expression in rat calvarial cells after 24hr........ 126 
Figure 4.56 Ephrin B1 relative level expression in MSCs after 24hr………………. 126 
Figure 4.57 Ephrin B1 relative level expression in rat cells at 72hr.……….……….  127 
Figure 4.58 Ephrin B1 relative level expression in MSCs at 72hr…………...…..… 127 
Figure 4.59 Ephrin B1 relative level expression in rat cells at 7days…………....…. 128 
Figure 4.60 Ephrin B1 relative level expression in MSCs at 7days……….……….. 128 
Figure 4.61 Ephrin B2 relative level expression in Rat cells after 24hr………....…. 130 
Figure 4.62 Ephrin B2 relative level expression in MSCs after 24hr……...……..… 130 
Figure 4.63 Ephrin B2 relative level expression in rat cells at 72hr……………....... 131 
Figure 4.64 Ephrin B2 relative level expression in MSCs at 72hr…………...…….. 131 
Figure 4.65 Ephrin B2 relative level expression in Rat cells at 7days.…………..…. 132 
Figure 4.66 Ephrin B2 relative level expression in MSCs at 7days………...…….. 132 
Figure 4.67 Ephrin B4 relative level expression in Rat cells after 24hr……..……...  134 
 
xvi 
Figure 4.68 Ephrin B4 relative level expression in MSCs after 24hr…………….… 134 
Figure 4.69 Ephrin B4 relative level expression in rat cells at 72hr………...…..…..  135 
Figure 4.70 Ephrin B4 relative level expression in MSCs at 72hr…………...….…. 135 
Figure 4.71 Ephrin B4 relative level expression in rat cells at 7days……...……….. 136 
Figure 4.72 Ephrin B4 relative level expression in MSCs at 7days………..………. 136 
Figure 5.1: Flowchart of puramatrix hydrogel scaffold preparation……………….. 142 
Figure 5.2:  Rat calvarial cells grown after 24hr on 0.1% Puramatrix in normal 
media, cells adhered while others formed clusters ……………………………..... 
146 
Figure 5.3:  Rat calvarial cells grown after 24hr on 0.25% Puramatrix in normal 
media, cells formed cluster,s note that the hydrogel breakage is clearer than 
0.1%............................................................................................................................ 
147 
Figure 5.4:  Rat calvarial cells grown after 24hr on 0.5% Puramatrix in normal 
media, cells formed clusters and some communicates with each other ……………. 
148 
Figure 5.5:  Rat calvarial cells grown after 24hr on 1% Puramatrix in normal 
media, some cells formed clusters and some adhered to the hydrogel scaffold ….... 
149 
Figure 5.6:  Rat calvarial cells grown at 7days on 0.1% Puramatrix in normal 
media, most of the cells adhered to the plate surface with few clusters................... 
150 
Figure 5.7:  Rat calvarial cells grown at 7days on 0.25% Puramatrix in normal 
media, most of the cells adhered to the plate surface with few clusters …………… 
151 
Figure 5.8:  Rat calvarial cells grown at 7days on 0.5% Puramatrix in normal 
media, most of the cells adhered to the plate surface with few cellular clusters 
152 
 
xvii 
contacting each other.................................................................................................. 
Figure 5.9:  Rat calvarial cells grown at 7days on 1 % Puramatrix in normal media, 
few cells adhering to the surface with cellular clusters ……………………............ 
153 
Figure 5.10:  Rat calvarial cells grown after 24hr on MAPTrix hydrogel cells 
adhered to the surface of the scaffold ………………………………….................... 
154 
Figure 5.11:  Rat calvarial cells grown at 7days on MAPTrix hydrogel cells 
adhered to the surface of the scaffold ………………………………...................... 
155 
Figure 5.12:  shows hydrogel drops of puramatrix (a) 0.1% (b) 0.25% (c) 
0.5%........................................................................................................................... 
156 
Figure 5.13:  Shows hydrogel drops of Puramatrix (a) 0.1% low magnification (b) 
0.1% high magnification (c) 0.25% low magnification (d) high magnification (e) 
0.5% low magnification (f) high magnification …………………………………… 
157 
Figure 5.14:  Shows SEM images of Puramatrix hydrogel where nanofibers are 
more dense at higher peptide concentrations (a) 0.1% (b) 0.25% (c) 0.5% (d) 1% ... 
159 
Figure 5.15:  Shows SEM images of rat calvarial cells grown on the surface of 
0.1% Puramatrix hydrogel …………………………................................................. 
160 
Figure 5.16:  Shows SEM images of rat calvarial cells grown on the surface of 
0.25% Puramatrix hydrogel, some cells formed clusters and some adhered to the 
surface………………………………………………………………………………. 
161 
Figure 5.17:  Shows SEM images of rat calvarial cells grown on the surface of 
0.5% Puramatrix hydrogel, few clusters and most of the cells adhered to the 
surface forming monolayer...................................................................................... 
162 
 
xviii 
Figure 5.18:  Shows SEM images of rat calvaria cells grown on the surface of 1% 
Puramatrix hydrogel, cellular clusters formed and few of the cells adhered to the 
surface of the scaffold…………………………………………………………..…. 
163 
Figure 5.19 Graph shows the viability of encapsulated calvarial rat cells after 24hr. 165 
Figure 5.20 Graph shows the viability of encapsulated human MSCs after 24hr…... 165 
Figure 5.21 Graph shows the viability of encapsulated calvaria rat cells at 72hr.......  166 
Figure 5.22 Graph shows the viability of encapsulated human MSCs at 72hr........... 166 
Figure 5.23 Graph shows the viability of encapsulated calvaria rat cells at 7days..... 167 
Figure 5.24 Graph shows the viability of encapsulated human MSCs at 7days…... 167 
Figure 5.25 Graph shows the alkaline phosphatase activity level of encapsulated 
calvaria cells after 24hr………………………………………………………….... 
170 
Figure 5.26 Graph shows the alkaline phosphatase activity level of encapsulated 
human MSCs after 24hr………………………………………………………...…... 
170 
Figure 5.27 Graph shows the alkaline phosphatase activity level of encapsulated 
calvarial cells at 72hr…………………………………………………………..…… 
171 
Figure 5.28 Graph shows the alkaline phosphatase activity level of encapsulated 
human MSCs at 72hr…………………………………………………………..……. 
171 
Figure 5.29 Graph shows the alkaline phosphatase activity level of encapsulated 
calvarial cells at 7days………………………………………………………..…...... 
172 
Figure 5.30 Graph shows the alkaline phosphatase activity level of encapsulated 
human MSCs at 7days  …………………………………………………...……........ 
172 
 
xix 
Figure 5.31 ALP relative expression level in encapsulated calvarial cells after 24hr 174 
Figure 5.32 ALP relative expression level in encapsulated MSCs after 24hr............ 174 
Figure 5.33 ALP relative expression level in encapsulated calvarial cells at 72hr…. 175 
Figure 5.34 relative expression level in encapsulated MSCs at 72hr……………..... 175 
Figure 5.35 ALP relative expression level in encapsulated calvarial cells at 7days... 176 
Figure 5.36 ALP relative expression level in encapsulated MSCs at 7days…...…… 176 
Figure 5.37 RUNX 2 relative expression level in encapsulated calvarial cells after 
24hr ………………………………………………………………………..……….. 
178 
Figure 5.38 RUNX 2 relative expression level in encapsulated MSCs after 24hr….. 178 
Figure 5.39 RUNX 2 relative expression level in encapsulated calvarial cells at 
72hr…………………………………………………………………………………. 
179 
Figure 5.40 RUNX 2 relative expression level in encapsulated MSCs at 72hr….…. 179 
Figure 5.41 RUNX 2 relative expression level in encapsulated calvaria cells at 
7days…………………………………………………………………………..……. 
180 
Figure 5.42 RUNX 2 relative expression level in encapsulated MSCs at 7days...…. 180 
Figure 5.43 SP7 relative expression level in encapsulated calvarial cells after 24hr. 182 
Figure 5.44 SP7 relative expression level in encapsulated MSCs after 24hr…….…. 182 
Figure 5.45 SP7 relative expression level in encapsulated calvaria cells at 72hr…... 183 
Figure 5.46 SP7 relative expression level in encapsulated MSCs at 72hr ……….… 183 
Figure 5.47 SP7 relative expression level in encapsulated calvaria cells at 7days .... 184 
 
xx 
Figure 5.48 SP7 relative expression level in encapsulated MSCs at 7days………… 184 
Figure 5.49 CX43 relative expression level in encapsulated calvarial cells after 
24hr…………………………………………………………………………………. 
186 
Figure 5.50 CX43 relative expression level in encapsulated MSCs after 24hr.......... 186 
Figure 5.51 CX43 relative expression level in encapsulated calvarial cells at 72hr... 187 
Figure 5.52 CX43 relative expression level in encapsulated MSCs at 72hr………... 187 
Figure 5.53 CX43 relative expression level in encapsulated calvarial cells at 7days. 188 
Figure 5.54 CX43 relative expression level in encapsulated MSCs at 7days……….  188 
Figure 5.55 Ephrin B1 relative expression level in encapsulated calvarial cells after 
24hr…………………………………………………………………………………. 
190 
Figure 5.56 Ephrin B1 relative expression level in encapsulated MSCs after 24hr... 190 
Figure 5.57 Ephrin B1 relative expression level in encapsulated calvarial cells at 
72hr…………………………………………………………………………………. 
191 
Figure 5.58 Ephrin B1 relative expression level in encapsulated MSCs at 72hr........ 191 
Figure 5.59 Ephrin B1 relative expression level in encapsulated calvarial cells at 
7days………………………………………………………………………………... 
192 
Figure 5.60 Ephrin B1 relative expression level in encapsulated MSCs at 7days...... 192 
Figure 5.61 Ephrin B2 relative expression level in encapsulated calvarial cells after 
24hr…………………………………………………………………………………. 
194 
Figure 5.62 Ephrin B2 relative expression level in encapsulated MSCs after 24hr 194 
 
xxi 
Figure 5.63 Ephrin B2 relative expression level in encapsulated calvarial cells at 
72hr…………………………………………………………………………………. 
195 
Figure 5.64 Ephrin B2 relative expression level in encapsulated MSCs at 72hr........ 195 
Figure 5.65 Ephrin B2 relative expression level in encapsulated calvarial cells at 
7days………………………………………………..……………………………..... 
196 
Figure 5.66 Ephrin B2 relative expression level in encapsulated MSCs at 7days….. 196 
Figure 5.67 Ephrin B4 relative expression level in encapsulated calvaria cells after 
24hr………………………………………………………………………………… 
198 
Figure 5.68 Ephrin B4 relative expression level in encapsulated MSCs after 24hr... 198 
Figure 5.69 Ephrin B4 relative expression level in encapsulated calvarial cells at 
72hr…………………………………………………………………………………. 
199 
Figure 5.70 Ephrin B4 relative expression level in encapsulated MSCs at 72hr........ 199 
Figure 5.71 Ephrin B4 relative expression level in encapsulated calvarial cells at 
7days………………………………………………………………………………... 
200 
Figure 5.72 Ephrin B4 relative expression level in encapsulated MSCs at 7days...... 200 
 
 
xxii 
Table of contents 
 
Declaration …………………………………………………………………….. i 
Acknowledgment ……………………………………………………………… ii 
Abstract ……………………………………………………………………….. iii 
List of abbreviations ………………………………………………………….... vi 
List of tables ………………………………………………………………….. vii 
List of figures ………………………………………………………………….. viii 
Table of contents ……………………………………………………………….. xxiii 
Chapter 1: literature review ……………………………………………….…. 1 
1.1 Introduction …………………………………………………….…………. 1 
1.2 Biomaterials in orthopaedics …………….……………….………………. 2 
1.3 Self- assembly peptides …………………………………………………… 7 
1.4 Three dimensional (3D) cultures…………………………………………… 10 
1.5 Bone signalling…………………….………………………………………. 15 
    1.5.1 Bone remodelling………………………………………………………. 15 
    1.5.2 Eph/ephrin signaling in bone…………………………………………… 17 
1.6 Project aims…………………………………………………………………. 21 
Chapter 2: General materials and methods…………………………………. 22 
2.1 Materials and methods ……………………………………………………… 22 
    2.1.1 Cell culture ……………..………….………………………………… 22 
    2.1.2 Cell counting and viability determination using a hemocytometer…… 23 
 
xxiii 
    2.1.3 Cell viability and proliferation assay………………………………….. 24 
    2.1.4 Alkaline phosphatase assay …………....…………………....…………. 26 
   2.1.5 RNA extraction and cDNA synthesis ………………..…………..……. 27 
      2.1.5.1 RNA isolation………………………………………………………. 27 
     2.1.5.2 RNA quantity and quality assessment……………………………… 29 
     2.1.5.3 RNA integrity assessment…………………………………………… 30 
     2.1.5.4 First-Strand cDNA synthesis………………………………………. 30 
    2.1.6 Quantitative real time polymerase chain reaction (qRT-PCR) …….….. 31 
    2.1.7 Scanning electron microscopy [SEM]………………………………… 33 
    2.1.8 Histology and immunoflourescent studies…………………………… 34 
      2.1.8.1 Samples preparation for histological studies………………………. 34 
      2.1.8.2 Immunoflourescent staining………………………………………. 36 
     2.1.9 Statistical analysis…………………………………………………….. 37 
Chapter 3: Investigating spheroids generation using different approaches.. 38 
3.1 Introduction ………………………………………………………………… 38 
3.2 Materials and methods ……………………………………………………… 40 
   3.2.1 Stock solutions preparation …….…………………………………….. 40 
      3.2.1.1 Methylcellulose stock solutions …………………..………………. 40 
      3.2.1.2 Poly-HEMA stock solutions ……………...………………………… 40 
      3.2.1.3 Agar stock solutions ………………...……………………………… 40 
   3.2.2 Cell culture……………………………………………………………… 40 
      3.2.2.1 Rat calvarial cell culture………………………………………….. 41 
 
xxiv 
      3.2.2.2 Multicellular spheroid culture………………………………………. 41 
      3.2.2.3 Evaluation of cell viability and number using the MTT assay……… 43 
      3.2.2.4 Image analysis………………………………………………………. 43 
3.3 Results ……………………………………………………………………… 44 
   3.3.1 Efficiency of spheroid formation………………………………………... 44 
 3.3.1.1  96 round -bottom plates……………………………………………. 44 
  3.3.1.2 Serum free media………………………………………………….. 44 
     3.3.1.3 Hanging drop method………………………………………………. 44 
     3.3.1.4 Methylcellulose cell entrapment…………………………………….. 45 
     3.3.1.5 PolyHEMA coated dish…………………………………………….. 45 
     3.3.1.6 Liquid overlay technique……………………………………………. 46 
   3.3.2 Cell viability and number………………………………………………. 57 
      3.3.2.1 96 U plate…………………………………………………………… 57 
  3.3.2.2 Serum free media……………………………………………………. 57 
      3.3.2.3 Methylcellulose cells entrapment……..……………………………. 58 
      3.3.2.4 PolyHEMA coated dish……………………………………………. 58 
     3.3.2.5 Liquid overlay technique……………………………………………. 59 
    3.3.3 Analysis of spheroid size and number in different culture environments 68 
3.4 Discussion …………………………………………………………………... 71 
  
 
xxv 
Chapter 4: Investigating cell gene expression and communication in 2D 
and 3D cultures………………………………………………………………… 
77 
4.1 Introduction ………………………………………………………………… 77 
4.2 Materials and methods ……………………………………………………… 78 
   4.2.1 Cell culture ……………....…………………………………………….. 78 
      4.2.1.1Poly-HEMA stock solution…………………………………………. 78 
      4.2.1.2 Preparation of Poly-HEMA Coated Plates………………………… 78 
      4.2.1.3 Rat calvarial cell culture …………………………………………… 78 
      4.2.1.4 Human mesenchymal stem cells cell culture ………………………. 78 
   4.2.2 Histology and Immunofluorescent studies……………………………... 78 
      4.2.2.1 Hematoxylin and eosin staining ……………………………………. 78 
      4.2.2.2 Immunofluorescent staining ……………………………………….. 79 
   4.2.3 Scanning electron microscopy [SEM] ………………………………….. 79 
   4.2.4 Evaluation of cell viability and proliferation using MTT assay ………... 79 
   4.2.5 Alkaline phosphatase assay ……………………………………………. 79 
   4.2.6 RNA isolation and quantitative real time polymerase chain reaction ….. 79 
   4.2.7 Statistical analysis ………………………………………………………. 80 
4.3 Results ……………………………………………………………………… 81 
   4.3.1 Connexin 43 localisation in 2D and 3D culture ……………………… 81 
   4.3.2 Morphological analysis of spheroids …………………………………… 92 
   4.3.3 Cell Viability in 2D and 3D …………………………………………… 101 
 
xxvi 
   4.3.4 Alkaline phosphatase assay ……………………………………………. 105 
   4.3.5 Changes in gene expression between 2D and 3D culture ……………… 109 
4.4 Discussion …………………………………………………………………... 137 
Chapter 5: In vitro osteogenic differentiation of cells encapsulated within a 
nanofiberous environment…………………………..………..……………….. 
140 
5.1 Introduction ………………………………………………………………… 140 
5.2 Materials and methods ……………………………………………………… 141 
   5.2.1 Cell culture …………………………………………………………….. 141 
      5.2.1.1. Rat calvaria cell culture …………………………………………… 141 
      5.2.1.2 Human mesenchymal stem cells cell culture ……………………….. 141 
   5.2.2 Hydrogel scaffold preparation ………………………………………… 141 
      5.2.2.1 Self-assembling peptide nanofibres ……………………………….. 141 
      5.2.2.2 Mussel adhesive protein …………………………………………… 142 
   5.2.3 Scanning electron microscopy [SEM] ………………………………….. 143 
   5.2.4 Evaluation of cell viability using the MTT assay ………………………. 143 
   5.2.5 Alkaline phosphatase assay …………………………………………… 143 
   5.2.6 RNA isolation and quantitative real time polymerase chain reaction…... 144 
   5.2.7 Statistical analysis ……………………………………………………… 144 
5.3 Results …………………………………………………………………….. 145 
   5.3.1 Morphological observations …………………………………………… 145 
   5.3.2 SEM morphology study ……………………………………………… 158 
   5.3.3 Cells viability in the hydrogel environment ……………………………. 164 
   5.3.4 Alkaline phosphatase activity assay ……………………………………. 168 
  5.3.5 Modulation of gene expression by cells interacting with the hydrogel 173 
 
xxvii 
matrix …………………………………………………………………………. 
5.4 Discussion …………………………………………………………………. 201 
Chapter 6: Final conclusions and future work…………………………….… 204 
References ……………………………………………………………………… 209 
Appendix A ………………………………………………………………….. 227 
Appendix B………………………………………………………………….. 229 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1 
 
Chapter 1: Literature review 
1.1 Introduction 
     The term tissue engineering emerged in 1987; it was coined by Professor Y. C. Fung at 
University of California (Lanza, Langer et al. 2007). Tissue engineering is defined as “the 
use of a synthetic or natural biodegradable material, which has been seeded with living 
cells when necessary, to regenerate the form and/or function of a damaged or diseased 
tissue or organ in a human patient” (Lanza, Langer et al. 2007). As indicated in the 
definition tissue engineering may involve three elements cells, nutrients [growth factors 
and cytokines], and scaffolds (TAKEI 2005) [figure1.1]. These scaffolds can be made 
either from synthetic or natural materials or a combination of the two (Khang, Kim et al. 
2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Tissue engineering three key elements (Khang, Kim et al. 2007) 
Tissue engineering 
Time Appropriate environment 
Regeneration of tissues / organs 
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1.2 Biomaterials in orthopaedics 
     The use of biomaterials in orthopaedics started thousands of years ago 3000 BC 
(Pietrzak 2008). Where raw materials such as wood and gold were commonly used to 
repair or restore bone defects (Pietrzak 2008) [figures 1.2 and 1.3].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: A mummy skull with a golden plate used to repair a defect at 
the front of the skull [cranioplasty] (Pietrzak 2008) 
Figure 1.3: An amputated toe replaced with a wooden one (Pietrzak 2008) 
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     Since then significant progress has been made using different materials in artificial 
implants, commonly metals, ceramics, and polymers particularly in orthopaedic field 
(Yarlagadda, Chandrasekharan et al. 2005). Today, there are several biomaterials that 
have the potential to be used as scaffolds in tissue engineering for both bone and cartilage 
repair [table 1.1] (Haasper, Zeichen et al. 2008).  
 
 
 
 
 
 
Biological materials Synthetic materials 
 perichondrium 
 SIS (small intenstinal submucosa) 
 collagen (I) sponge 
 collagen (I)-GAG 
(glycosaminoglykan) 
 collagen (II)-GAG 
 collagen (III)-GAG 
 fibrin 
 hyaluronan 
 gelatin 
 alginate 
 agarose 
 chitosan 
 periost 
 DBM (demineralized bone matrix) 
 allogeneic/xenogenic bone 
 PL (Polylactic acid) 
 PGLA (Polyglycolicacid and 
copolymers) 
 CF-PU-PLLA (Carbonfibre-
Polyurethane-Poly 
 (L-lactide)-Graft) 
 CF-Polyester (Polyester-
Carbonfibre) 
 PU (Polyurethane) 
 PLLA (Capralactone (Poly-L-
Lactide/epsilon- 
 Caprolactone) 
 PLLA-PPD (Poly- L-Lactic Acid 
and Poly- p-Dioxanol) 
 PVA-H (Polyvinylalcohol-
Hydrogel) 
 ß-TCP (Tricalcium phosphate) 
 CDHA (Calcium-deficient 
hydroxyapatite) 
Table 1.1: Illustrates the different types of natural and synthetic materials available to be  used as 
scaffolds in orthopaedic tissue engineering for both cartilage and bone (Haasper, Zeichen et al. 2008) 
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     Materials are classified according to their origin into natural and synthetic (Mark 
2004). Natural materials include those that can be found in the extracellular matrix 
[ECM] such as collagen and laminin (Saha, Pollock et al. 2007), alginate (Hutmacher, 
Goh et al. 2001). Whereas polyethylene glycol (PEG), poly 2-hydroxyethylmethacrylate 
(PHEMA), are examples of synthetic materials (Lee 2005). Both materials have 
drawbacks, the former can be expensive with a potential for contamination and may cause 
unfavourable immune responses (Saha, Pollock et al. 2007). whilst the synthetic materials 
are less expensive and more reproducible compared to the natural materials, they may 
also cause immune reaction (Yarlagadda, Chandrasekharan et al. 2005).  
     Despite the presence of a wide range of  materials, there is still a need to find the 
optimal material that can fully replace both structural and biochemical parameters to 
resemble the original tissue (Kutz 2009). [Table1.2]. Both natural and synthetic materials 
are usually used to achieve the structural parameter only, while the biochemical 
parameters are integrated through cells or immobilized signals (Kutz 2009).  
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Structural components Biochemical components 
Physical properties 
 Shape 
 Size 
 Pore features 
 Three-dimensional 
 Surface topography 
 
Immobilized signals 
 ECM proteins 
 Adhesive peptides 
 Growth factors 
Mechanical properties 
 Reinforced composites 
 Mechanical loading 
 Electrical stimuli 
 
Diffusible signals 
 One- component system 
 Two-component system 
 Gene delivery 
Chemical properties 
 Hydrophobicity 
 Charge 
 Biodegradation 
 
Living components  
 Cell seeding 
 Differentiated cells  
 Scaffold pre-vascularization 
 Cells for neuro-regeneration  
 Combination therapy 
 Stem cells 
 Commercial, cell-based products 
 
 
     This led scientists to draw attention to what is called “smart biomaterials”, which 
refers to biomaterials that behave at the structural or functional levels by responding to 
changes in the surrounding environment (Fairman and Akerfeldt 2005). For instance, a 
sequence of amino acids/peptides in a specific arrangement responds to changes in 
temperature or pH or the presence of particular ions, resulting in the formation of 
different structures [figure 1.4] (Fairman and Akerfeldt 2005).  
Table 1.2: In tissue engineering several parameters are taken into consideration to optimize biomaterials 
for tissue regeneration and in particular two main categories: structural and biochemical. Optimizing 
structural parameters includes the physical, mechanical, and chemical properties. While biochemical 
parameter optimization are incorporated through immobilized signals, diffusible signals, and/or living 
components.(Meilander and Bellamkonda 2004) 
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Figure 1.4: Examples of different structures of self -assembled peptides (Fairman and Akerfeldt 2005) 
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Consequently, this directs the attention of researchers towards self-assembling peptide 
systems as a highly controllable and functional biomaterial scaffold. 
1.3 Self- assembly peptides: 
     The molecular self-assembly process can be defined as “the spontaneous organization 
of molecules under thermodynamic equilibrium conditions into structurally modified 
arrangements due to non-covalent interactions” (Aggeli, Boden et al. 2001). Even though 
the first scientist who suggested exploitation of these events in order to fabricate new 
devices was Eric Drexler in 1981 (Rajagopal and Schneider 2004), it is only recently that 
self-assembly peptide based materials emerged as a new method to fabricate at the 
nanoscale from the bottom-up approach (Ryadnov 2007) giving the opportunity for three 
dimensional assembly (Lu and Lieber 2007).   
     Inspired by naturally self- assembled systems such as DNA, protein folding, and lipids 
(Rajagopal and Schneider 2004) materials have been designed to assemble spontaneously 
governed by non- covalent forces including ionic bonding, hydrophobic effects, hydrogen 
bonds, and Van der Waals interactions (Mirkin and Niemeyer 2007).  
     According to (Aggeli, Boden et al. 2001) self-assembly peptides can be classified into 
three types:  
1) Self -assembling peptides type I: also known as “Molecular Lego” for the reason 
that they assemble in a specific order like Lego bricks (Zhang 2003). The 
assembly process in this system is driven by the intermolecular forces based on 
the presence of alternating charged amino acids [figure 1.5] (Zhang 2003). When 
introducing the deigned peptide to a physiological solution it assembled 
spontaneously forming a hydrogel [figure 1.6A] build of nanofibers [figure 1.6B] 
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which can be used as scaffolds to support cell attachment, proliferation, and 
differentiation (Aggeli, Boden et al. 2001). Hence most of the peptide materials 
that have been studied thus far are of this type (Aggeli, Boden et al. 2001).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2) Self -assembling peptides type II: also called “molecular switch” , due to their 
ability to change molecular structure based on the surrounding environment  
(Aggeli, Boden et al. 2001). For example,  DAR 16-IV  which consist of 16 amino 
acids that form a β-sheet structure at a specific temperature (Aggeli, Boden et al. 
2001). However, it undergoes a conformational transformation from the β to α 
helical structure at different temperature and pH (Zhang 2003). This type of 
Figure 1.6:   (A) self-assembled Puramatrix 1%    (B) Puramatrix SEM image shows the formation of 
nanofibers (10-20 nm)   (TAKEI 2005) 
(A) (B) 
Figure 1.5:   Puramatrix molecular model (TAKEI 2005) 
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material can be useful in protein-protein interactions and disease caused by 
protein folding disruption studies (Zhang 2003). Where it was found that the 
structural transformation of DAR 16-IV is similar to that seen in diseases 
associated with accumulation of β sheet structures such as Alzheimer (Zhang and 
Rich 1997).  
 
 
 
 
 
 
 
 
 
 
3) Self-assembling peptide III:  With this type of peptide the molecules self- 
assemble on a surface  forming a layer that is a few millimeters thick , and for that 
reason it’s called “molecular paint” or “molecular carpet” [figure 1.8] (Zhang 
2003). This kind of peptide consists of three parts, the first part is the ligand that 
can be recognized by the cell surface or other molecules, the second part forms a 
linker while the third is the surface anchor (Zhang 2003). Due to the presence of 
regions that the cell surface or other molecules can be attach to,  this type of 
peptide is also known as “molecular Velcro” (Aggeli, Boden et al. 2001). 
Accordingly,  it is a useful tool in cell-cell behaviour and communication studies 
(Zhang 2003).  
Figure 1.7.: Molecular model of  DAR 16-IV (Zhang 2003) 
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     Self-assembly peptides can be used as scaffolds in 3D cell culture (Fichman and Gazit 
2014); providing nanoscale features which are important to determine cell behaviour and 
interaction with the substrate (Haycock 2011).  
1.4 Three dimensional (3D) cultures: 
    Cell shape and relationships with neighbouring cells are fundamental parts of 
controlling cell activity. Examples of this are clear in development and tissue formation. 
More often than not embryonic stem cells [ESs] differentiate in two ways, either directly 
from pluripotent cells or via a non-adherent spheroids cellular aggregation forming what 
is known as embryoid bodies [EBs] (Rungarunlert, Techakumphu et al. 2009). The 
formation of these spheroids enables cell-cell interaction, which influences the course of 
ESC differentiation (Rungarunlert, Techakumphu et al. 2009). The earliest records in 
spheroids formation was on cancer research  in the 80’s (Sutherland, Carlsson et al. 
1981). It was reported that cells have the ability to reorganized and spontaneously formed 
3D spheroids (Pallua and Suschek 2010). To stimulate cell aggregation in vitro, a wide 
Figure 1.8: (A) cells grown in a designed pattern coated with molecular carpet peptides (B) Molecular 
model of RADSC-14 which forms a monolayer on surface and attract specific molecules (Zhang 2003) 
(A) 
(B) 
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range of 3D culture systems are available varying from simple and cheap to a more 
complicated or rather expensive methods. The methods include the conventional 
“hanging drop” method, static suspension, the use of low adherence 96 multi-well round 
bottom plate, bioreactors, and finally cell encapsulation/entrapment using a semi solid 
medium such as methylcellulose or alginate [figure 1.9] (Rungarunlert, Techakumphu et 
al. 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9: An overview of the common 3D culture methods adapted from (Rungarunlert, 
Techakumphu et al. 2009) 
 
(A) Hanging drop culture  
 
(B) Static suspension 
culture  
 
Basic methods 
(C) Encapsulation of ES 
cell culture  
 
(E) Low adherence,96 well 
plate round bottom  
 
(D) Entrapment of ES 
cell culture  
 
(F) Low adherence,96 
well plate V bottom  
 
Alternative methods 
Bioreactors methods 
(G) Stirred / spinner flask 
suspension culture 
(H) STLV culture (I) HARV culture (J) Orbital shaker 
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Nowadays, most researchers are aware of the limitation of the traditional 2D cell 
culture (Gelain, Bottai et al. 2006). 3D culture systems can be considered more effective 
compared to the 2D culture systems (Baharvand, Hashemi et al. 2006), because they 
better resemble the natural in vivo 3D environment (Zhang, Chai et al. 2006). A 3D 
culture system plays an important role in helping and understand cellular development, 
communication, and signal transduction (Gelain, Horii et al. 2007). Previous studies have 
shown that cellular function, particularly cell signaling is different in a 2D culture 
compared to a 3D culture (Cukierman, Pankov et al. 2002). For example, specific extra 
cellular matrix [ECM] protein production may be reduced by cells grown in a 2D culture 
system (Gelain, Bottai et al. 2006). This may be due to the fact that in a 2D culture, cells 
are attached to the plate surface from one side and communicate with the adjacent cells 
from the other side, but the remaining parts are exposed to the culture media (Gelain, 
Horii et al. 2007). So, in 2D culture an interaction between cell and the plastic surface is 
prevail rather than cell/cell and cell/ECM interaction which form normal cell function 
basis (Achilli, Meyer et al. 2012).  In contrast, in a 3D culture cells are surrounded with 
the extracellular matrix [ECM] and other cells mimicking the in vivo environment 
(Gelain, Bottai et al. 2006).  
     It is well known that tissues are composed of heterogeneous cell population with 
interactions between stroma, vessels, and nerves (Fennema, Rivron et al. 2013). 
Moreover, studies have found that osteogenic differentiation increased (Rouwkema, de 
Boer et al. 2006) as well as Wnt signalling pathway activation in heterotypic cell 
communication (Saleh, Whyte et al. 2011). This complex interplay require a 3D 
environment, here the use of spheroids as a tool to investigate intercellular and cell/ECM 
13 
 
interactions is vital (Fennema, Rivron et al. 2013). For instance, lack of vascular network 
limits the size of tissue engineering constructions, so, a 3D process in which vascular 
structure develops within another tissue may be the answer to the problem (Fennema, 
Rivron et al. 2013). In a recent study by (Rivron, Raiss et al. 2012) spheroids have been 
used to engineer pre-vascularized bone which helped in improving the survival of 
implanted cells (Fennema, Rivron et al. 2013). Furthermore, bone defects e.g. 
osteoporosis and tumour resection are major clinical problems where conventional 
methods such as transplantation and bone filling material is insufficient  (Langenbach, 
Naujoks et al. 2013). Alternatively, bone tissue engineering promises new therapeutic 
opportunities via combination of cells, growth factors, and scaffolds  (Langenbach, 
Naujoks et al. 2013).  
Different biomaterial scaffolds can be used to form a 3D environment replicating the 
ECM to provide both physical structure and chemical compositions (Bajaj, Schweller et 
al. 2014). The choice of biomaterial type depends on the cell type used in the study, 
where different requirements are needed such as the mechanical properties and growth 
factors (Dhandayuthapani, Yoshida et al. 2011).   
    Scaffolds are divided mainly into two application categories: functional implants for 
regenerative and clinical applications, and in vitro 3D scaffolds for laboratory 
applications (Karamuk 2001). The characteristics of both scaffolds differ, where in the 
case of the implantable scaffolds it should match the defect size; promote cell growth, and 
biodegrade with no harmful effects. Whereas in the case of scaffolds used in the 
laboratory, supporting desired cell growth and differentiation are more important. Thus, 
there are different factors that should be considered when choosing a 3D cell culture 
system [figure 1.10] (3DBiomatrix 2012) 
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     Numerous studies have used 3D scaffolds to investigate different cell types and their 
growth and differentiation, such as neural progenitor cells (Ortinau, Schmich et al. 2010), 
cardiomyocytes (Mihic, Li et al. 2014), lung progenitor cells (Ling, Liu et al. 2014), and 
mesenchymal stem cells (Karadzic, Vucic et al. 2014).  The interest of this study is 
towards osteogenesis and bone signalling.  
 
 
Figure 1.10 : Diagram showing four main factors that should be considered when choosing 
a 3D cell culture environment; which include cell type, research needs, specific 
application, and budget. (3DBiomatrix 2012) 
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1.5 Bone signaling: 
1.5.1 Bone remodeling: 
     Bone tissue originates from mesenchymal stem cells [MSCs] that also give rise to  
chondrocytes, myoblasts, and adipocytes (Triffitt, Oreffo et al. 2001). Bone is composed 
of two contents cells and matrix (Firestein, Budd et al. 2008). The latter consists of 10% 
water, 70% inorganic component, and 20% organic component with 90% of this being 
collagen type I (Nakamura 2007). As regards to cells three types are present bone forming 
cells [osteoblasts], mechanically sensitive cells [osteocytes], and bone resorbing cells 
[osteoclasts] (Firestein, Budd et al. 2008). Osteoblasts are active cells that produce bone 
matrix along with other molecules which play a role in bone remodeling, activation and 
differentiation of osteoclasts (Firestein, Budd et al. 2008). Inactive osteoblasts can 
become osteocytes which are buried in bone matrix or if they remain at the surface of the 
bone termed as bone lining cells (Nakamura 2007).  
     Bone can be renewed where old bone matrix is replaced with new in a  process known 
as bone remodeling (Nakamura 2007). In 3 stages initiation, transition, and termination 
[see figure 1.11] bone remodeling is regulated by the communication of different cells 
including, bone vascular endothelial, marrow stromal cells, bone lining cells, osteoblasts, 
and osteoclasts (Matsuo and Irie 2008).  
 
 
 
 
Figure 1.1: Bone remodeling three phases which involves bone resorption 
and formation (Matsuo and Irie 2008) 
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     In the initiation phase, recruitment of osteoclasts occurs through chemokines produced 
by stromal cells and vascular endothelial cells [e.g. SDF1], and osteoblasts [e.g. MCP-1] 
(Matsuo and Irie 2008). Osteoclasts are directed to the bone surface that require repair  by 
bone sensory cells the osteocytes which determine the surface that will be resorbed 
(Matsuo and Irie 2008).It has been suggested that osteoclast differentiation occurs 
beneath the bone lining cells (Matsuo and Irie 2008).  
The second stage is the transition phase and as the name suggests it involves the transition 
from bone resorption to bone formation (Matsuo and Irie 2008).  Coupling plays a vital 
role in this stage,  where  bone formation by osteoblasts is activated by osteoclasts either 
by a direct cell – cell contact [e.g. Eph/ephrin pathway] or indirectly by stimulating the 
production of growth factors [e.g. TGF-β], and bone morphogenetic proteins [BMPs] 
(Matsuo and Irie 2008).  
     In the last phase bone formation continues and may last for approximately three 
months, unlike bone resorption that lasts for only a short period  (Matsuo and Irie 2008). 
 
 
 
 
 
 
 
 
Figure 1.12: Osteoclast – osteoblast interaction in bone remodeling 
 a + b initiation phase [bone lining cells blue] [osteoclast red] 
c + d transition phase [bone lining cells blue] [osteoblast dark blue] [osteoclast red] 
e + f termination phase (Matsuo and Irie 2008) 
17 
 
1.5.2 Eph/ephrin signaling in bone: 
     Over the last few years signaling via Eph/ephrin proteins has attracted the attention of 
many researchers, because of their involvement in diseases such as cancer and 
osteoporosis (Edwards and Mundy 2008). In addition, they play an important role in cell 
migration (Holder and Klein 1999), immune regulation (Edwards and Mundy 2008), and 
bone homeostasis (Edwards and Mundy 2008). Ephrins were first identified in 
erythropoietin producing hepatocellular carcinoma cell line (Edwards and Mundy 2008). 
Eph/ephrins signaling involves two classes a GPI linked protein [class A], and 
transmembrane protein [class B]  (Holder and Klein 1999). Eph receptors consist of 8 
receptors type A and 6 type B, while ephrin ligands consist of 5 types A and 3 type B 
(Jensen 2000). Generally, a B type ligand binds to a B type receptor, and A ligand to A 
receptor (Kullander and Klein 2002). However, there are some exceptions, for example 
Eph A4 can bind to both A and B type ligands (Kullander and Klein 2002) [see table 
1.15]. Furthermore, Eph receptors can act as ligands and vice versa (Kullander and Klein 
2002). Additionally, since both Eph receptors and ephrin ligands are bound to the 
membrane, signaling through Eph/ephrin requires cell – cell contact (Kullander and Klein 
2002).   
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Figure 1.13: Eph receptors and ephrin ligands structure (Kullander and Klein 2002) 
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Eph receptors ephrin ligands 
Eph A1 ephrin A1 
Eph A2 ephrin A3, A1, A5, A4, A2 
Eph A3 ephrin A5, A2, A3,A1,A4, and B1(weak) 
Eph A4 ephrin A5, A1, A3, A2, B2, B3, A4  
Eph A5 ephrin A5, A1, A2, A3, A4  
Eph A6 ephrin A2, A1, A3, A4, A5  
Eph A7 ephrin A2, A3, A1, A4, A5 
Eph A8 ephrin A5, A3, A2  
Eph B1 ephrin B2, B1, A3, A1(?), A4(?), B3(?) 
Eph B2 ephrin B1, B2, B3  
Eph B3 ephrin B1, B2, B3  
Eph B4 ephrin B2, B1,  
Eph B5 Unknown 
Eph B6 Unknown 
  
     In general bone cells express ephrin B1, ephrin B2, Eph B2, Eph B3, Eph B4,  Eph B6,  
and Eph A4 (Xing, Kim et al. 2010). Osteoclasts express ephrin B1 and B2 ligands but 
not receptors (Kwan Tat, Pelletier et al. 2009), whereas osteoblasts express Eph B4 and 
ephrin B2 (Edwards and Mundy 2008). Eph/ephrin in bone involves what is known as 
bidirectional signaling, where cell expressing Eph receptors [forward signaling] interact 
with cell expressing ephrin ligands [reverse signaling] (Mundy and Elefteriou 2006). 
Most studies have focused on Eph B4 / ephrin B2 interactions while ephrin B1 was the 
focus for others.  
Table 1.3: Eph receptors and ephrin ligands specificities arranged depending on their affinity, based on 
structure and function ephrins are divided into two groups ephrin-A and ephrin-B. EphA receptors bind to 
ephrin-A ligands and Eph-B receptors bind to ephrin-B ligands with few exceptions shown in the table 
(Jensen 2000) 
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     In the Eph B4 / ephrin B2 interactions in bone, for ephrin B2 reverse signaling to be 
activated the inhibition of Fos and NFATC1 are required (Mundy and Elefteriou 2006). 
On the other hand, Eph B4 forward signaling depends on Rho inactivation in osteoblasts 
(Mundy and Elefteriou 2006). It worth mentioning that Rho can be activated via Eph A 
receptor leading to the formation of lamellipodia and filopodia, and resulting in changes 
in movement and cell shape (Edwards and Mundy 2008).  
     Eph B4 increases bone formation and decreases bone resorption (Mundy and 
Elefteriou 2006), whereas the stimulation of  Eph B4 forward signaling is through ephrin 
B2 (Edwards and Mundy 2008).  In addition,  ephrin B1 is important for bone marrow 
stromal cells differentiation, osteoblasts differentiation, osterix expression stimulation, 
and bone formation (Xing, Kim et al. 2010). Moreover, ephrin B2 interacts with connexin 
43 and thereby regulates cellular communication via gap junctions (Kwan Tat, Pelletier et 
al. 2009). 
 
 
 
 
 
 
 
 
 
 
Figure 1.14: Eph/ephrin signaling in bone homeostasis (Mundy and Elefteriou 2006) 
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1.6 Project aims 
     The main aim of this study was to examine cell behaviour in a 3D environment where 
cell/cell and cell/ECM communication could be explored.  This included investigating 
RAD-16 peptide that self assembles forming a hydrogel scaffold for cells and allowing 
the presentation of cell interaction motifs. This allowed investigation of the role of 3D 
interactions in the control of MSC differentiation.  
Specific objectives were the following: 
1)  To optimize in vitro spheroid culture conditions in order to evaluate 
differentiation of marrow-derived mesenchymal cells in 3D. 
2) To determine cell viability in 2D and 3D culture using the MTT assay. Also cell 
differentiation to osteoblasts will be assessed via alkaline phosphatase enzyme 
activity measurement, and through quantifying osteoblastic gene expression 
using qRTPCR.  
3) To investigate cell response to RAD-16 self-assembly peptide assessing cell 
viability and ability to differentiate into osteoblasts. 
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Chapter 2: Materials and Methods 
2.1 Materials and methods: 
All materials and reagents were purchased from Sigma-Aldrich company, Ltd Ayrshire, 
UK unless otherwise specified. 
2.1.1 Cell culture 
     Tissue culture was carried out in an aseptic environment using a class II laminar flow 
hood which had been decontaminated with 70% ethanol. Two cell types were used in this 
study, rat calvaria-derived osteoprogenitor cells and human mesenchymal stem cells, both 
were grown as monolayer [2D] and aggregates (spheroids) [3D] under normal and 
osteogenic conditions. The normal media for routine culture was Dulbecco's Modified 
Eagle Medium [DMEM/Gibco BRL, UK] supplemented with 10% fetal bovine serum 
[FBS], 10% 2mML-Glutamine, 100µg/ml streptomycin and 100U/ml penicillin. To 
promote osteogenic differentiation the media was supplemented with 5mM of β-
Glycerophosphate disodium salt hydrate, 100 µg/ml of 2-Phospho-L-ascorbic acid 
trisodium salt and 10nM of dexamethasone. Dexamethasone is a synthetic glucocorticoid 
that has been shown in previous studies to induce the osteoblastic phenotype and thus 
bone formation (Atala and Lanza 2001). β-Glycerophosphate is added as a source of 
phosphate to promote the matrix mineralization process (Atala and Lanza 2001). While 
ascorbic acid works as a cofactor for proline hydroxylation which is important in collagen 
triple helix stabilization (Atala and Lanza 2001).  After seeding; the cells were incubated 
at 37º C in a 5% co2 atmosphere for 24hour, 72hour, and 7 days. Cultures were observed 
using a phase contrast inverted microscope. 
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2.1.2 Cell counting and viability determination using a hemocytometer: 
     The number of cells in culture can be determined using either a hemocytometer or 
coulter counter, in this study a haemocytometer was used. A hemocytometer is a thick 
glass slide with two chambers; each one is divided with gridlines into nine squares each 
of which is 1mm square (Adams 2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2.1: Illustration of a hemocytometer slide. After placing the coverslip on the slide, a cell suspension is 
loaded and cells are counted in each square. Cells touching the middle line on the top and left are included in the 
counting (green) while those touching right and bottom are excluded from the count (red) (Phelan 2007; Ortinau, 
Schmich et al. 2010)  (Martin 1994) 
Grid 
1mm 
1mm 
Cover slip 
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     To determine the number and viability of cells per millilitre, first both coverslip and 
hemocytometer were cleaned with 70% [v/v] ethanol then after cell trypsinzation a 100µl 
of the cell suspension and a 100µl of Trypan blue dye were mixed, using a sterile pipette 
and about 10µl of cell suspension was loaded and cells in 4 squares were counted. To 
determine the percentage of viability the number of viable cells [nonstained] was divided 
by the total number of cells and multiplied by 100 (Adams 2003) 
 
 
Then the following equation was used: 
Cells/ml = average count per square x dilution factor x 10
4
 
 
2.1.3 Cell viability and proliferation assay: 
     Measuring cell viability and proliferation is important in cell- based studies (Kresse 
2003). A decrease in cell viability reflects a reduction in cell growth, while an increase in 
cell viability which assesses healthy cells indicates cell proliferation (Kresse 2003). 
Several viability assays are available which are based on measuring the metabolic activity 
[e.g., MTT, XTT, WST-1] or by examining cell membrane integrity using a dye that 
stains dead cells [e.g., trypan blue] (Kresse 2003).  
     In this study cell viability and proliferation were measured using an MTT assay which 
is a colorimetric assay that measures the 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide (MTT- yellow coloured) reduction by the succinate dehydrogenase 
enzyme produced by active mitochondria in live cells resulting in the formation of 
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formazan (dark purple insoluble crystals) (Chapdelaine 1989). The insoluble formazan 
can be solubilized using an organic solvent e.g. isopropanol or DMSO and measured at 
570nm OD using a colorometric plate reader (Chapdelaine 1989).  
 
 
 
 
 
 
 
 
    Cell proliferation and viability were assessed as described by (Wirth, Comte et al. 
2005). First, the media were discarded from the wells and 200µl of MTT solution with a 
final concentration of 1mg/ml was placed in each well.( 24 well plate) the cells were then 
incubated for 4h at 37ºC. Thereafter, media were removed and 100µl of isopropanol was 
added to solubilize the formazan crystals completely; the plates were placed on a shaking 
plate for 30 min at room temperature. Using a microplate reader the plates were read at 
570nm OD. Next, the absorbance values were blanked against isopropanol absorbance 
and cell viability was measured following the equation below: 
 
 
Figure 2.2: Represents the chemical structure of MTT and its reduction by 
mitochondrial enzymes in viable cells to formazan (Duval, Clarot et al. 2012) 
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Where: 
As = Sample absorbance 
Ab = Blank absorbance 
Ac = Control absorbance  
 
2.1.4 Alkaline phosphatase activity  
      Alkaline phosphatase is an enzyme that is found in most tissues but is extensively in 
placenta, kidney and bone (Wilson and Walker 2000). To assess alkaline phosphatase 
activity a colorimetric assay with 4-nitrophenylphosphate (PNPP) was used where 
alkaline phosphatase cleaves this colourless substrate to a yellow product known as p-
nitrophenol. 
 
 
 
 
 
 
      First the media were removed and the cells were fixed in 4% (w/v) paraformaldehyde 
in PBS for 10 min, followed by washing with 50mM HEPES buffer (pH = 8 ). Then 
200µl of alkaline phosphatase colorimetric substrate (pNPP) was added and left at room 
temperature for about 30 min. The absorbance of the end product was measured at 
405nm.  
Figure 2.3: Represents the chemical structure of a p-nitrophenol molecule  which is hydrolysed by 
alkaline phosphatase developing a yellow end product (Sigma)  
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      The alkaline phosphatase enzyme activity was calculated via interpolation of a 
standard curve which was generated by making a serial dilution from a concentrated 
solution containing 1ml of 50mM HEPES buffer (pH = 8 ) and 20μl of 10mM  p-
nitrophenol standard to give a concentration range of 0.2, 0.1, 0.05, 0.025, 0.0125 and 
0.00625μM/ml, respectively. 
2.1.5 RNA extraction and cDNA synthesis 
2.1.5.1 RNA isolation: 
     RNA isolation can be performed using different methods either by disrupting both 
plasma membrane and subcellular organelles with chaotropic agents such as Sodium 
docedyl sulphate (SDS), N-Lauryl sarcosine, urea, chloroform, guanidinium salts, or 
phenol (Farrell Jr 2010). or by solubilizing the plasma membrane gently maintaining 
organelle integrity using non-ionic lysis buffer (Farrell Jr 2010). In this study RNA was 
isolated using Guanidinium thiocyanate-phenol-chloroform extraction method with the 
TRIzol reagent which disrupts the cell and dissolves cell components but maintains RNA 
integrity.  
     For this study TRIzol
®
 reagent (Invitrogen) was used according to the manufacturers 
protocol. Media were removed and cells were washed with PBS (Lonza), then 1ml 
TRIzol per 10 cm
2
 of culture dish surface area was added to lyse the cells. After 5 min at 
room temperature the viscous solution was pipetted up and down several times for 
complete nucleoprotein dissociation. 0.2ml of chloroform per 1ml of TRIzol was then 
added and mixed vigorously for 15 s and incubated at room temperature for 2-3 min. The 
samples were spun at 13,000 xg for 15 min and 3 layers were formed [see figure 2.4]. The 
colourless aqueous upper phase that contains the RNA was transferred to a new tube for 
subsequent analysis.  RNA was precipitated by adding 0.5ml of ice cold isopropanol 
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(Fisher) followed by incubation at room temperature for 10 min RNA was collected by 
centrifugation at 12,000 xg 4Cº for 10 min and the RNA pellet formed on the base side of 
the tube. Afterward the supernatant was removed leaving the RNA pellet which was 
washed by adding 1ml of 70% ethanol and then the samples were vortexed briefly and 
then centrifuged again for 5 minutes at 7500xg 4Cº. After removing the supernatant the 
pellet was air dried for about 5-10 min, never allowing the RNA pellet to dry completely. 
Then the pellets were re-suspended in 20-50µl RNase free water followed by incubating 
in a water bath at 65ºC for 5 min and samples were then ready to be quantified.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Cells grown in tissue culture 
Centrifuge for 
15min. at 
13,000 xg 
Transfer to a 
tube and add 
chloroform 
Homogenization 
 phase 
Separation phase 
Pellet  
Tip  
Remove the aqueous solution 
containing RNA to a new tube 
and add 500µl Isopropanol 
Spin at 1200xg 
for 10min. 
Wash with 70% 
ETHO. and spin at 
7500xg for 5min. 
Pellet  
Tip  
Remove ETHO. And 
air dry 
Pellet  
Add 20-50µl of 
RNase free water and 
incubate in water bath 
65º for 5 min. to 
dissolve the pellet 
then cool in ice and 
quantify RNA with 
Nanodrop 
Figure 2.4: schematic of RNA extraction steps   
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2.1.5.2 RNA quantity and quality assessment: 
    Different methods may be used for RNA quantification including UV absorbance, 
micro capillary electrophoresis, and fluorescence based quantification (Aranda, Dineen et 
al. 2009). In this study RNA concentration and purity was measured using a Nano-drop 
1000 spectrophotometer (Thermo scientific) following the manufacturers protocol. 
Briefly, with the arm open a 1µl of the sample was placed into the lower measurement 
pedestal and the upper pedestal was lowered, after closing a closed liquid cell is 
automatically formed between both lower and upper pedestal and a spectral measurement 
is made [see Figure 2.5] . The ratio between 260/280 nm readings provide an estimation 
of nucleic acid purity, where values of 1.8 and 2 is accepted as pure DNA and RNA 
respectively (Roskams and Rogers 2002).  Subsequently, samples were ready for cDNA 
synthesis. 
 
 
 
 
Figure 2.5: Measuring RNA using the Nanodrop instrument (A) pipette the sample into the lower 
measurement pedestal, with the sampling arm open. (B) 1µl of the sample. (C) when the sampling arm 
is closed the spectral measurement is initiated using the operating software on the PC, automatically 
the sample column is drawn between the upper and the lower measurement pedestals.   
(A) (B) 
(C) 
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2.1.5.3 RNA integrity assessment: 
     RNA integrity was assessed by running it on a 1.2% agarose gel formed by melting 
0.6g of electrophoresis grade agarose in 50 ml of 1x TAE buffer 2 µl of 10 mg/ml 
ethidium bromide (EtBr) stock solution was also added to the molten agarose. The gel 
was poured in a casting frame and the comb was inserted and left to solidify for about 
[20-30 min]. Once the gel was set the comb was removed and the gel placed in 1x TAE 
buffer 1 µl 8x loading dye and 6 µl diH2O with 2 µl of each RNA sample was loaded into 
each well of the solidified gel, and a DNA ladder 2kb was also loaded. The gel was run at 
100v for approximately 30-40 min. Then the nucleic acids were visualized using UV 
illumination. Two distinct bands should appear if the RNA is intact.  
 
2.1.5.4 First-Strand cDNA synthesis:  
      cDNA was prepared from approximately 1µg of RNA using SuperScript III first-
strand cDNA synthesis kit (Invitrogen) following the manufacturer’s protocol. In brief, 
the samples were mixed with 1µl of 50µM  Oligo (dT) (Promega) and 2 µl of 10mM 
dNTP mix and heated in a water bath at 65ºC for 5 min. After that the samples were 
incubated for at least 1 minute on ice followed by centrifugation and adding 4µl 5x First-
Strand Buffer, 1µl 0.1M DTT, 1µl Recombinant RNase Inhibitor (40units/µl), and 1µl of 
SuperScript III Reverse Transcriptase (200 units/µl). Then cDNA synthesis was 
performed in a 20µl reaction volume by incubating for 60 min at 50ºC using a Thermo-
cycler, and samples were then used for qPCR amplification.  
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2.1.6 Quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR): 
    Once cDNA was obtained, qRT-PCR assays for multiple genes [listed in table 2.2 and 
2.3] were performed with a Real –Time PCR system, ABI Prism 7900HT (Applied 
Biosystem) using SYBR Advantage qPCR Premix (Clontech) following manufacture 
recommendations. The PCR reaction mixture was prepared by mixing 10µl of x2 SYBR 
Advantage qPCR Premix, 0.4µl of 10µM PCR forward primer, 0.4µl of 10 µM PCR 
reverse primer, 2µl of cDNA template, and 7.2µl of free nuclease water to achieve a total 
volume of 20µl in each well of a 96well plate. The plate was then placed in the ABI 
Prism 7900HT, the thermal profile used is shown in table 2.1. 
 
Procedure Temperature Time 
Hot start 50 Cº 2 minutes 
 
 
                     x40   
 
 
 
95 Cº  
95 Cº  
60 Cº 
 
10 minutes 
15 seconds 
1 minute 
 
Dissociation curve 
95 Cº 
60 Cº 
95 Cº 
15 seconds 
15 seconds 
15 seconds 
 
 
 
Table 2.1: thermal cycles for genes amplification 
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     GAPDH expression levels were used in normalizing Ct values obtained for each gene.   
For qPCR assay specificity, a verification melt curve was generated and analysed where 
one defined peak suggests a clean amplification of a single product, while multiple peaks 
suggest the presence of more than one product which may be caused by primer dimer or 
non-specific amplification. The genes explored in this study are shown in table 2.2 and 
table 2.3. 
 
 
Gene Forward primer Reverse primer 
GAPDH CTGCACCACCAACTGCTTAC CAGAGGTGCCATCCAGAGTT 
Runx2 CCGTGTCAGCAAAACTTCTTT CTCACGTCGCTCATCTTGC 
ALP GCACAACATCAAGGACATCG TCAGTTCTGTTCTTGGGGTACAT 
Osterix GGACAGCCAACCCTAGCC TGGAGCCACCAAACTTGC 
CX 43 AGCCTGAACTCTCATTTTTCCTT CCATGTCTGGGCACCTCT 
Pannexin 3 ATCTCTCTGGCCTCACAAGG CAGCACTGGCAGATACATGG 
Ephrin B1 GCCAAGCAAAGAGTCAGACA TCTTGCTGGTTCACAGTCTCAT 
Ephrin B2 TCCTCATGAAAGTTGGACAAGA CTGGACGTCTTGTTGGATCA 
Ephrin B4 CTGCGGAACATCTGACTCG TGATGTTAACTTTCCCTGTTGC 
Table 2.2: list of rat primers [Sigma] used for qRT-PCR analysis 
33 
 
 
 
Gene Forward primer Reverse primer 
GAPDH AGCCACATCGCTCAGACAC GCCCAATACGACCAAATCC 
Runx2 GTGCCTAGGCGCATTTCA GCTCTTCTTACTGAGAGTGGAAGG 
ALP CCTGCCTTACTAACTCCTTAGTGC CGTTGGTGTTGAGCTTCTGA 
Osterix CATCTGCCTGGCTCCTTG CAGGGGACTGGAGCCATA 
CX 43 TTTCAATGGCTGCTCCTC TGCTCACTTGCTTGCTTGTT 
Pannexin 3 GCTGATGTCCCTGGCATT GAGAAGCAGCTGATCGGAGA 
Ephrin B1 TCATGAAGGTTGGGCAAGA GTGTTGTCTGCCTCCTTGCT 
Ephrin B2 TCTTTGGAGGGCCTGGAT GATCCAGCAGAACTTGCATCT 
Ephrin B4 CCCCAGACTGTCCCACCT GCATTCCGGTCTTTCTGC 
 
 
2.1.7 Scanning electron microscopy [SEM]: 
 
     An electron microscope is an instrument that uses a beam of electrons to examine 
objects. SEM is used to observe the surface topography, chemical composition [via 
EDX], crystalline structure,  and the size and shape of a sample (Bogner, Jouneau et al. 
2007) (Vernon-Parry 2000). 
 
Table 2.3: list of human primers [Sigma] used for qRT-PCR analysis 
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     In order to study specimen topography, first, cell culture media were removed gently. 
Then, samples were washed with PBS followed by fixation in 2%(w/v) gluteraldehyde in 
Sorensons phosphate buffer for 30 min. They were washed with PBS and dehydrated 
using an ascending grade of ethanol [25%, 50%, and 75%] for 30 min then 100% ethanol 
x2 changes for 1 h. Samples were then finally dehydrated using Hexmethyldisilazane 
[HDMS] in a fume hood overnight at room temperature. Following this, samples were 
mounted on aluminium stubs with carbon discs (Agar Scientific, UK) and coated with 
15nm of gold using a Polaron SEM coating unit (Bozzola 1998).  
 
 
2.1.8 Histology and immunoflourescent studies: 
2.1.8.1 Samples preparation for histological studies: 
      For 2D histological studies, cells were grown on a slide/cover glass which was placed 
in a petri dish and cells were left to grow for 7 days. After removing the media and 
washing with PBS, samples were fixed in 4% paraformaldehyde in PBS [w/v].  
     For analysis of 3D specimens, samples were first gently washed with PBS gently and 
the spheroids fixed for 10 min with 4% paraformaldehyde in PBS [w/v]. They were then 
placed in collodion bag which was made following (Shidham and Atkinson 2007).  
Briefly, a conical Pyrex tube was filled with collodion solution and left to dry in a fume 
hood for about 10 minutes. The dried layer that forms at the top of the tube was punctured 
and the extra collodion solution was placed in a container for reuse. Once it had 
completely dried and coated the wall of the tube, PBS was added to wash the bag and 
then the spheroids were placed inside and the bag was released from the tube. The 
collodion bag containing the spheroids were rolled and wrapped in a tissue paper then 
placed in a histology processing cassette.  
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     The samples were embedded in paraffin wax, they were then sectioned [5 m thick] 
using a Leica microtome (Leica Microsystems Ltd., U.K.) and the sections were placed 
on poly-L-lysine-coated slides which were left to dry at room temperature.  
     Haematoxylin and Eosin (H&E), a routine stain was used, which stains nuclei bluish-
purple and cytoplasm pink. First, sections were deparaffinised in xylene for 10 minutes 
followed by rehydrating with ethanol 100% and 95% respectively for 3 minutes at each 
concentration. After rinsing in dH2O sections were treated with Harris’s haematoxylin for 
Figure 2.6: Cell block preparation with a collodion bag (Shidham and Atkinson 2007) 
Fill with 
collodion and 
Let for 10 min. 
Puncture the 
dried layer and 
decant the extra 
solution 
Keep the tube 
inverted and let 
the collodion coat 
the tube wall 
Add PBS to loosen the 
collodion bag then place 
the spheroid and remove 
the bag using forceps 
Roll the bag 
gently and cut the 
excess, then roll 
in a tissue paper 
Place it in a 
processing 
cassette 
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5 minutes then washed in dH2O then in Scott’s water for 2minutes. Staining with eosin 
was followed for 1 minute, then washing in dH2O. Finally, dehydrating through a series 
of ascending concentrations of ethanol [50% - 70% - 95% - 100% - 100%] for 2 minutes, 
followed by clearing  in xylene for 2 minutes. Sections were then mounted in DPX and 
stored in a cool dry place. 
2.1.8.2 Immunoflourescent staining: 
     Immunofluorescence (IF) is a technique where antibodies are chemically conjugated to 
a fluorescent dye such as tetramethyl rhodamine isothiocyanate (TRITC) or fluorescein 
isothiocyanate (FITC). Two methods are available direct and indirect binding of 
antibodies to the antigen of interest allowing detection through fluorescence techniques. 
The fluorescence can then be quantified using an array scanner or automated imaging 
instrument, or flow cytometer, or visualized using fluorescence or confocal microscopy 
(Robinson, Sturgis et al. 2009). 
 
 
 
 
 
 
 
 
 
 
     For monolayer [2D] cells were grown on a coverslip and left to grow for 7 days. 
Whereas in the case of the spheroids [3D] cells were grown on the coated surface of the 
Figure 2.7: Schematic of direct and indirect Immunofluorescence methods (Robinson, Sturgis et al. 2009) 
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24 well plate, the spheres then were moved gently to a new non-coated well.  In both 
cases [2D and 3D] the media were aspirated and cells were washed then fixed in 4% 
[w/v] paraformaldehyde in PBS for 20 min, then washed three times in PBS/0.1% Tween 
20 [v/v] for permeabilization. Non-specific binding of antibodies was blocked by 3% 
(v/v) goat serum in PBS/0.1% Tween 20 [v/v] for 20 min. Sections were incubated for 
one hour at room temperature with a primary monoclonal anti-connexin 43 antibody 
[1:100 dilution]. Followed by washing three times with PBS/0.1% Tween 20 [v/v], and 
incubating with FITC secondary antibody [1:200 dilution] for 45 minutes in the dark. 
Sections were rinsed with PBS/0.1% Tween 20 [v/v] then mounted with ‘Vectashield 
with DAPI’ (Vector Laboratories Ltd., Peterborough U.K.) and incubated overnight at 
4°C in the dark. The stained specimens in this study were visualized using both 
fluorescence and confocal microscopy.  
 
 
2.1.9 Statistical analysis:  
     Data management and analysis was performed using SPSS 17.0 (Statistical Product 
and Service Solutions 17.0, Chicago, IL, USA). Variables were tested first to verify if 
they follow a Gaussian distribution. Since the analysis showed that our data were not 
normally distributed a non-parametric test, a Kruskal-Wallis one-way analysis of variance 
was conducted. The variance was then subjected to a multi-comparison analysis Mann – 
Whitney U test to determine the significance. Results were presented as mean ± standard 
error, and a p-value of < 0.05 was considered significant. 
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Chapter 3: Investigating spheroids generation using different 
approaches  
 
3.1 Introduction 
      Due to the limitations of traditional monolayer cell culture (Gelain, Bottai et al. 2006), 
three dimensional cell culture have been developed that are considered to be more 
effective at mimicking the in vivo scenario and are therefore more representative at 
modelling cell activity (Baharvand, Hashemi et al. 2006). 
      Different 3D culture methods are available to study cell aggregation and the formation 
of spheroids in vitro, which can be classified in to scaffold and non-scaffold based 
methods (Riss 2014). The latter includes serum free media (Pease, Brewer et al. 2012), 
the hanging drop method (Yusuf, Gopurappilly et al. 2013), rounded bottom 96 well plate 
(Kawai, Hayashi et al. 2001), agar (Kang, Jenabi et al. 2007), methylcellulose (Baum, 
Hlushchuk et al. 2007), poly (2-hydroxyethyl methacrylate) [PolyHEMA] (Le Beyec, Xu 
R Fau - Lee et al. 2007), rotating spinner flasks (Lin and Chang 2008), micro-patterned 
surfaces (Wang, Itaka et al. 2009), and magnetic levitation (Souza, Molina et al. 2010). 
The quantity and quality of these spheroids is affected by different factors including 
spheroid culture method choice, culture media, and viability (Atala and Lanza 2001).  
     Accordingly in this chapter we aimed to optimize in vitro spheroid culture conditions 
for the cells in this study by testing different simple methods to identify which of these 
methods is the most appropriate and reproducible. Figure 3.1 summarizes the 
optimization plan. 
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Figure 3.1: 3D optimization plan 
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Figure 3.1: 3D optimization plan 
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3.2 Materials and methods: 
All materials and reagents were purchased from Sigma-Aldrich company, Ltd Ayrshire, 
UK unless otherwise specified.  
3.2.1 Stock solutions preparation: 
3.2.1.1 Methylcellulose stock solutions:  Methylcellulose stock solutions were 
prepared as described in (Longati, Jia et al. 2013). Briefly, methylcellulose powder 
was autoclaved then dissolved in DMEM media [w/v]. Three concentrations were 
made 0.01% (Baum, Hlushchuk et al. 2007) [w/v], 1% [w/v] (Dang, Kyba et al. 
2002), and 3% [w/v]. 
 
3.2.1.2 PolyHEMA stock solutions: Poly-HEMA crystals was dissolved in 95% 
ethanol by placing the tube in a shaker at room temperature overnight; four 
concentrations were prepared 10mg/ml (Zhang, Xu et al. 2010), 20mg/ml (Dhawan, 
Jeffreys et al. 2008), 30mg/ml, and 40mg/ml.  
 
3.2.1.3 Agar stock solutions: three concentrations were prepared 0.5% [w/v] (Kunz-
Schughart and Freyer 2002) , 1% [w/v]  (Yu, Dillon et al. 1999), and 2% [w/v]  
(Ulrich, Jain et al. 2010) by dissolving the agar in phenol red-free media or PBS.  
3.2.2 Cell culture: 
     Tissue culture was carried out following protocols described in section 2.1.1. 
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     3.2.2.1 Rat calvarial cell culture: 
     Rat calvarial cells were isolated by Dr. Mark Birch; and preserved in 10% 
dimethylsulfoxide [DMSO] with bovine serum, they were then stored in liquid nitrogen.  
A cryovial containing frozen cells was placed in a water bath at 37º C and the cells were 
thawed quickly by swirling the vial gently. The outside of the vial was then dried, the vial 
transferred to a class II tissue culture hood and wiped with 70% ethanol. DMEM/10% 
FCS media was added slowly and the cells transferred to a T75-flask and grown until they 
were ready to be used [80-90% confluent, passage 3-4]. 
     In this experiment cells were grown for 24 h, 48 h 7 d, 14 d, 21 d, and 28 d in normal 
Dulbecco`s modified Eagle`s medium [DMEM] supplemented with 10% foetal bovine 
serum [FBS], 10％ 2mM L-Glutamine, 100 μg/mL streptomycin and 100 U/mL 
penicillin. To promote osteogenic differentiation, the media was replaced after 24h with 
growth media supplemented with 5mM of Glycerol 2-phosphate disodium salt hydrate, 
100 μg/ml of 2-Phospho-L-ascorbic acid, and 10nM dexamethasone. Cells were seeded at 
four densities of approximately 14 x10
5
, 6 x10
5
, 3.5 x10
5 
, and 0.5 x10
5
 cells/ml.  
  3.2.2.2 Multicellular spheroid culture: 
 96 U plate: 
160µl of cells suspension were dispensed into the well and left to grow. 
 Serum free media: 
1000µl of cells suspension in a free serum media were dispensed in to the well of 
a 24 well plate and left to grow. 
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 Hanging drop method: 
In this method drops of 20µl of cell suspension were placed on the inside of the 
lid of a 60mm Petri dish filled with sterile PBS or media (Del Duca, Werbowetski 
et al. 2004). The lid was then inverted over the dish so the drops are hanging from 
the lid [see figure 3.1]  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 Represents drawing of hanging drop technique. The lid of the 
petri dish was removed to place drops of cells suspension. The petri dish 
was filled with PBS to prevent drops drying. The lid was then placed again 
carefully.  
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 Methylcellulose cells entrapment: 
This method was performed according to the method of (Kubota, Preisler et al. 
1981). The cell suspension was mixed in 0.01% - 1% - 3% methylcellulose media 
and this was then dispensed in a 24 well plate.  
 PolyHEMA coated dish: 
A 24 well plate was coated with 50µl of polyHEMA solution and left to dry 
overnight at room temperature. The coated plates were sterilized using UV light 
before seeding the cells. 
 Liquid overlay technique:  
400 µl of each agar solution [0.5%, 1%, and 2%] concentration was placed in a 24 
well plate and left to solidify. Cells were then seeded onto this surface and placed 
in the incubator.  
 
3.2.2.3 Evaluation of cell viability and number using the MTT assay: 
     Cellular spheres were collected in an eppendorf tube and spun to form a pellet. The 
media was then discarded and MTT assay was performed as described in section 2.1.3.  
3.2.2.4 Image analysis: 
    The morphological appearance of the cells was observed and images were taken using 
an inverted light phase microscope. The numbers of cell spheroids were counted and the 
diameters of these spheroids were measured in 6 fields in each well plate. Data analysis 
was performed using SPSS 19.0. [SPSS Inc., USA]. Data was considered statistically 
significant when p value ≤ 0.05.   
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3.3 Results: 
3.3.1 Efficiency of spheroid formation: 
3.3.1.1  96 round -bottom plates: 
     As shown in figure [3.3] after 24hr, 48hr and 7 days of culture cells attached to the 
surface of the well under both normal and osteogenic conditions. However, it was 
noticed that few cells were de-attached at low density [figure 3.4]. 
    At day 14, 21, and 28 cells were still attached to the well surface at high cellular 
densities, whereas at low densities some cells still remained unattached. Interestingly, 
white precipitate was noticed under osteogenic conditions which started at day 14 in 
high cell density [figure 3.5] while the precipitate started to appear at day 21at low cell 
density [figure 3.6].  
3.3.1.2 Serum free media: 
          As shown in figure [3.7] some cells grown after 24hr, and 48hr attached while 
others remained suspended in the media. After 7 days cellular accumulation was noticed 
at high density [figure 3.8]. And at day 14, 21 and 28 most cells grown in osteogenic 
media were suspended, though some cells are still attached at low density [figure 3.9]. 
       Overall, removing the serum from the media didn’t induce cell aggregation at either 
short or long term time points either in normal or osteogenic media. 
   3.3.1.3 Hanging drop method: 
       As it can be seen in figure [3.10], after 24hr cells were rounded in shape and after 
48hrs spheres were formed, although some cells managed to attach to the lid surface 
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[figure 3.11]. After 7, 14, 21, and 28 days spheres grown under osteogenic conditions 
started to disintegrate [figure 3.12]. 
   3.3.1.4 Methylcellulose cell entrapment 
      This method was used to form a semisolid media for cell entrapment. As seen in 
figure [3.13] most cells attached to the plastic surface while some cells were rounded at 
all methylcellulose concentrations and very few spheres were seen at high densities after 
24hr. After 48hr, 7, 14, 21, and 28 days cells were still attached with very few rounded 
cells. Moreover, it was noted that after 21, and 28 days some cells grown under 
osteogenic media de-attached and formed irregular cellular clusters compared to cells 
grown under normal conditions [figure 3.14]. Additionally, precipitates were noted at 
high methylcellulose concentrations.  
   3.3.1.5 PolyHEMA coated dish 
       PolyHEMA was used as anti-adherent coating on tissue culture plastic. Preliminary 
data showed that the quality of the coating played a role in spheroid formation.  When the 
plate was placed in the laminar flow hood for alcohol evaporation during surface 
preparation, subsequently some cells adhered to the well surface while others formed 
spheres [figure 3.2]. Therefore, to get a good coating the plates were left on the bench for 
a slower more even evaporation.  
      Figure [3.15] shows that rounded spheroids were formed after 24hr.  Also, it was 
noted that at high cell density the quality of the spheres were better compared to low 
density, where sphere margins were irregular. In addition, after 14 days spheroids grown 
in osteogenic media started to dissociate [figure 3.16]. Furthermore, the size of the 
spheres was larger and the numbers were less in long term culture.  
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      Comparing different concentrations of PolyHEMA shows that at higher concentration 
[40mg/ml] specifically after 14d the polyHEMA surfaces were broken [figure 3.17]. 
  3.3.1.6 Liquid overlay technique 
      Agar can be used either to form a semi solid media for cells entrapment as in the case 
of methylcellulose, or to coat the surface of the culture plate as a way to prevent cells from 
adhering. In figure [3.18] it can be seen that after 24, and 48hr cells aggregated and 
formed irregular spheres at higher cell density, and in 1% and 2% agar compared to 0.5% 
there were a few cells that were attached but most of them were rounded in shape [figure 
3.19]. After 7, 14, 21, and 28 days cells formed a large cluster with a high starting cell 
density [figure 3.20] compared to low seeding densities where some cells were suspended 
but most of the cells attached to the well plate surface [figure 3.21]. 
 
 
 
 
 
 
 
 
 
 
Figure 3.2 Shows an uneven polyHEMA coating that led to cells attaching in some areas, 
while some cells aggregate and formed spheres.   
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Figure 3.4: Low density of calvarial cells grown on the surface of a 96u rounded 
bottom plate at 7days cells adhered to the surface with few cells floating in the 
medium. 
Figure 3.3: Calvarial cells grown on the surface of a 96u rounded bottom plate 
where cells adhered to the surface after 24hr.  
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Figure 3.5: Calvarial cells grown under osteogenic conditions on the surface of 
a 96u rounded bottom plate, precipitate appeared [arrow] at day 14 at high cell 
density 
Figure 3.6  Calvarial cells grown under osteogenic conditions on the surface of 
a 96u rounded bottom plate, precipitate appeared [arrow] at day 21 at low cell 
density 
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Figure 3.7 Calvarial cells grown on the surface of a 24 well in a serum free 
media some cells attached to the surface while other cells were suspended in the 
media after 24hr. 
Figure 3.8 High densities of calvarial cells grown on the surface of a 24 well in a 
serum free media at 7days where cells started to aggregate [arrow] 
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Figure 3.9 Calvarial cells grown on the surface of a 24 well in a serum free 
media at 14days under osteogenic conditions where most cells are suspended 
though few cells are still attached  
Figure 3.10 Calvarial cells grown using hanging drop technique cells were 
rounded and didn’t attach after 24hr  
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Figure 3.11 Calvarial cells grown after 48hr using hanging drop technique 
where some cells attached to the surface of the lid [black arrow] while other 
cells formed sphere [red arrow]. 
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Figure 3.12 Calvarial cells grown at 21days using hanging drop technique 
where cells that aggregated and formed spheres started to disintegrate [black 
arrow]  
Figure 3.13 Calvarial cells grown after 24hrin normal media mixed with 
methylcellulose  where some cells attached to the plate surface [black arrow] 
while other cells aggregated [red arrow]. 
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Figure 3.14 Calvarial cells at 21days grown in osteogenic media mixed with 
methylcellulose where cells formed irregular accumulation [black arrow]  
Figure 3.15 Calvarial cells grown after 48hr on the surface of 24 well plate 
coated with polyHEMA to prevent cells from attachment, as a result cells 
aggregated and form spheroids  
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Figure 3.16 Calvarial cells grown on the surface of a 24 well plate coated with 
polyHEMA shows spheroids disintegration after 14days of culture 
Figure 3.17 Shows the surface of high concentration [40mg/ml] polyHEMA 
coating which was broken after 14 days  
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Figure 3.18 Calvarial cells grown after 24hr on the surface of 24 well plate 
coated with 2% agar shows the accumulation of cells in irregular shape  
Figure 3.19 Calvarial cells grown after 24hr on the surface of 24 well plate 
coated with 0.5% agar shows cells adhered to the surface [black arrow] while 
most of the cells were suspended in the media [red arrow]. 
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Figure 3.20: Calvarial cells grown after 14 days shows the formation of large 
spheroid by time at high cells density  
Figure 3.21 Calvarial cells grown after 14 days shows cells suspended in the 
media while most of the cells attached to the surface of the well. 
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3.3.2 Cell viability and number: 
     Calvarial cell viability and number were assessed using MTT, a colorimetric assay 
where the compound is taken up by the cells and converted in the mitochondria to an 
insoluble coloured product. Therefore, low absorbance indicates a reduction in the 
number of viable cells and a higher absorbance indicates an increased number of cells.  
3.3.2.1 96 U plate: 
      As shown in figures 3.22, 3.23, 3.24, 3.25, 3.26, 3.27, 3.28, and 3.29 the viability 
of the cells seeded at high density decreased at 48hr but increased afterwards, while it 
remained steady at 21 day with a slight increase at 28 days. In contrast, cell numbers 
grown under osteogenic conditions increased slightly at day 7 but decreased gradually 
at 14, 21, and 28 days.  
     In the case of low cell seeding density, cell viability increased after 48hr and 
reached a peak at day 14. While cell number, grown in osteogenic media, increased 
after 48hr and decreased after 14d.  
    At a very low density cell viability increased after 24hr then started to decline after 
48hr, 7d, 14d, and 28d with a slight increase at 21d in both normal and osteogenic 
conditions.  
3.3.2.2 Serum free media: 
     As shown in figures 3.22, 3.23, 3.24, 3.25, 3.26, 3.27, 3.28, and 3.29cell viability at 
a high seeding density decreased at 48hr but increased afterwards at 7, and 14 days, 
and declined after 21d, however, the viability of cells grown in osteogenic media 
declined after 7d and plateaued at 21, and 28 days. 
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     In the second experiment with a high cell density and the first experiment with a 
low density the viability of cells grown in normal condition increased gradually after 
24hr and continue rising over time. While in osteogenic media it raised and reached a 
peak at 7 days but declined at 14, and 21 days, surprisingly increasing again at 28days.  
     In contrast, in the second experiment [seeded at low density] the viability of cells 
decreased after 48hr under both normal and osteogenic conditions, but almost remains 
steady after 7d in normal media and surprisingly increased after 21 days in osteogenic 
media.   
   3.3.2.3 Methylcellulose cells entrapment 
     Cell viability grown in normal media increased after 24hr and 48hr and continued 
increasing over time in both high and low density cell density cultures. On the one hand, 
high cell density cultures under osteogenic conditions showed increased viability after 
48hr and at 28 days. On the other hand, in the first experiment low density the viability of 
cells increased after 48hr and at 28 days with a slight decrease at 21 days, while in the 
second experiment low density seeding led to increased cell numbers after 48hr that 
continued rising over time in  0.01% of methylcellulose. But with high concentrations of 
methylcellulose (1%w/v and 3%w/v) cell number remains approximately constant after 
14 days.  
   3.3.2.4 PolyHEMA coated dish 
    The data shows that cell number under normal media conditions and at high density 
declined after 24hr and at 21d, but increased afterwards. In contrast, cell viability grown 
under osteogenic conditions remains steady in plates coated with 30, 40, and 20 mg/ml 
but a decrease in cell number was noted at 7d in wells coated with 10 mg/ml polyHEMA. 
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     At low density the viability of cells grown in normal and osteogenic media increased 
after 48hr, decreased at 21 days but increased again afterwards at 28 days.  
  3.3.2.5 Liquid overlay technique 
     The MTT assay revealed that cell viability increased considerably after 24hr under 
these culture conditions and reached a peak at 7d and declined after, but increased after 
21 days in cells grown on wells coated with 1% and 2% agar while it remained stable in 
0.5%. 
     Under osteogenic conditions cell viability increased after 48hr and at 28 days at high 
cell density and decreased after 7 days. While in low density it increased at 7 and 21 days 
and decreased at 14 and 28 days.  
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Figure 3.22: shows MTT Viability assay results for cells grown in normal media (n=1) with cell density 
approximately 14 x10
5
, .the vertical axis represents absorbance while horizontal axis represents time. 
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Figure 3.23: shows MTT Viability assay results for cells grown in osteogenic media (n=1) with cell density 
approximately 14 x10
5
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Figure 3.24: shows MTT Viability assay results for cells grown in normal media (n=1) with cell density 
approximately 6 x10
5
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Figure 3.25: is a graph that represents MTT Viability assay results for cells grown in osteogenic media 
(n=1) with cell density approximately 6 x10
5
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Figure 3.26: shows MTT Viability assay results for cells grown in normal media (n=1) with cell density 
approximately 3.5 x10
5
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Figure 3.27: shows MTT Viability assay results for cells grown in osteogenic media (n=1) with cell density 
approximately 3.5 x10
5
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Figure 3.28: shows MTT Viability assay results for cells grown in normal media (n=1) with cell density 
approximately 0.5 x10
5
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Figure 3.29: shows MTT Viability assay results for cells grown in osteogenic media (n=1) with cell density 
approximately 0.5 x10
5
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3.3.3 Analysis of spheroid size and number in different culture 
environments 
     Images were taken using an inverted phase microscope where both spheroid diameter 
and the number of spheroids in six fields and three  replicates were measured  using 
SPOT imaging software (Diagnostic Instruments, Sterling Heights, MI) [see figure 3.30]. 
To compare the diameter of the spheroids and number of spheroids formed in both normal 
and osteogenic media over time the data was first tested checked for normal distribution. 
Since the data was not normally distributed a non-parametric Kruskal-Wallis test was 
used, and the test results revealed that there were significant differences between groups 
with a p value less than 0.05. Afterwards, a multiple comparison Boneferroni test was run 
to determine which means differ.  
      As seen in figure 3.31 there was a significant difference in spheroid number between 
cells grown in normal and osteogenic media after 24hr, 48hr and 7days. Also, between 
spheroids grown in normal and osteogenic media after 48hr, but there was no significant 
change in spheroid number in normal and osteogenic media after 7 days. On the other 
hand, spheroids diameter was significantly altered between cells in normal media after 
24hr and cells in normal media after 48hr and 7 days. There was an also significant 
difference between spheroids grown in normal media after 24hr and spheroids grown in 
osteogenic media after 24hr and 48hr.  
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(a) 
 
Figure 3.30 shows spheroids number were counted and their diameter were measured using 
SPOT software (a)  spheroids generation on plates coated with poly-HEMA (b) Spheroids 
diameter measurement note the different size of the spheroid  
 
(b) 
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Figure 3.31 Data represents the mean ± standard error of the mean statistical significant determined 
using Kruskal-Wallis test n=18, p value ≤ 0.05 was considered significant where (*) indicates 
significance compared to normal media while (**) compared to 24hr (a) number of spheroids. (b) 
Spheroids diameter measurements  
 
* 
(a) 
** ** 
(b) 
** 
** 
* 
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3.4 Discussion:  
     Cells are usually grown as a monolayer in 2 dimensional cultures; however, previous 
studies have noted the relevance and importance of growing cells in 3 dimensions. For 
example, in evaluating drugs for cancer research, it was found that 3D cultures not only 
mimic the in vivo environment but also that cells grown in a 3D culture environment 
were more resistant to chemotherapeutic agents compared to those grown in 2D (Phung, 
Barbone et al. 2011). It was also reported that cells grown in monolayer differ 
physiologically compared to those grown in 3D culture (Khoei, Goliaei et al. 2004). In 
light of this 3D spheroid culture is a useful tool in modelling cell (patho) physiology.  In 
addition cell therapies for regenerative medicine will rely on the administration of cell 
suspensions and understanding how these cells aggregate both with each other and the 
host tissue will be fundamental for their long term success.     
     The present study aim was to test and compare different simple methods that will 
induce the formation of spheroids. Both the characteristics and the viability the cells 
under different culture conditions were evaluated.  
     It was reported before that spheroids formation is affected by various factors that 
include spheroid culture method choice, culture media, and cell viability (Atala and Lanza 
2001). The results of the work presented here reinforces the view that choosing the 
appropriate method for a specific study or cell type(s) will influence the successful 
formation of spheroids. For example, previous studies have reported that serum is 
necessary at the beginning of culture (Atala and Lanza 2001) . However, it has been 
suggested that serum should be eliminated after spheroids formation for optimal genes 
expression (Atala and Lanza 2001). For the reason that serum could return cells back to 
monolayer growth (Ghosh 2006). Moreover, studies showed that melanocyte spheroid 
formation decreased when serum concentration increased and the growth is reduced when 
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serum is completely removed (Lin, Hsiao et al. 2006). In contrast to previous findings 
where eliminating serum led to spheroid formation, the results of the present study 
showed that removing serum did not induce spheroids. This could be due to the cell type 
used in this study. Previous studies that have shown successful spheroid formation using 
different cell lines include dental pulp cells, (Xiao and Tsutsui 2013), human gall bladder 
carcinoma cells (Shi, Gao et al. 2011), mouse corneal keratocytes (Yoshida, Shimmura et 
al. 2005). While other researchers combined eliminating the serum factor with other 
methods such as using a gyratory shaker to shake the plates continuously preventing cells 
from adhering (Bao, Fisher et al. 2013). Also, seeding cells in an ultra-low attachment 96 
well plate (Liu, Ma et al. 2013) or low adhesion culture plates (Pease, Brewer et al. 2012) 
in a serum free media. This may suggest that eliminating serum alone may not be a good 
method for some cell types. In addition, the results of the work presented here does not 
support the findings of (Li, Pan et al. 1999) who demonstrated the importance of 
eliminating serum from the media in a non-adherent environment for spheroids 
generation. The cells used in our studies were able to aggregate and form spheroids in 
polyHEMA coated plates with the presence of serum in the media. Furthermore, it was 
reported that a high percentage of serum will permit the formation of a larger spheres 
(Raptis 2001). 
     On the other hand, our results show that using 96 rounded bottom plates failed to 
generate spheroids. Prior studies used this approach combined with other protocols such 
as coating the wells with agar (Ho, Yeap et al. 2012), or polyHEMA (Phung, Barbone et 
al. 2011) (Kurioka, Takagi et al. 2011), or mixing cells with agar  (Ke, Albers et al. 2004) 
or methylcellulose (Rudisch, Kuip et al. 2012) then seeding them in the 96 u plate. While 
others used spinning force to collect cells and help them form spheroids in 96 u bottom 
well plate (Kawai, Hayashi et al. 2001).  
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     The other method used in this study that failed to produce spheroids was 
methylcellulose which was used as a semi solid media for cells entrapment at three 
concentrations. Previous studies have used low concentration of methylcellulose 0.12% 
(Baum, Hlushchuk et al. 2007; Haycock 2011), 0.8% (Kubota, Preisler et al. 1981), and 
12mg/ml (Rudisch, Kuip et al. 2012). Also, this approach has been combined with other 
methods, (Baum, Hlushchuk et al. 2007) for example induction of cell aggregation using 
the hanging drop as well as methylcellulose where cells were mixed with 0.12% 
methylcellulose then pipette drops of the mixture into the petri dish cover.  Spheroid 
formation failure with this method could be due to cell type since it was reported that this 
method is usually used for hematopoietic cells (Liu, Ma et al. 2013). 
     By contrast, the hanging drop technique has been widely used by many researchers 
(Yusuf, Gopurappilly et al. 2013) (Tsukada, Kouki et al. 2013) . The results in this study 
found that using this method will induce cell aggregates, however, this method is 
technically challenging where gravity limits the volume of the droplet of cells suspension 
used ranging between 20-50µl  and therefore changing media is an obstacle (Lee, 
Ortmann et al. 2010) (Breslin and O'Driscoll 2013). In addition, using this method it is 
not suitable for the production of spheroids at a large scale (Rungarunlert, Techakumphu 
et al. 2009). These obstacles may be overcome using a commercial 384 well plate 
developed by 3DBiomatrix, or the InSphero hanging drop plate that allows the generation 
of spheroids at a larger scale (Hsiao, Tung et al. 2012). Additionally these plates are 
designed so it would be easy to replace old media with fresh media (Breslin and 
O'Driscoll 2013).  
     In contrast, coating plates with polyHEMA enhanced spheroid generation at all 
concentrations. In accordance with the present results, previous studies have 
demonstrated that coating plates with a non-adhesive polymer such as polyHEMA 
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enhances cellular spheroids formation (Schwartz, Lechene et al. 1991) (Le Beyec, Xu R 
Fau - Lee et al. 2007). This led companies such as Greiner Bio-One to manufacture 
CELLSTAR® cell repellent surface plates which are coated with a polymer to induce 
spheroids formation (Taylor 2013). The way polyHEMA works in preventing cells 
adherence may be due to negative electrostatic reduction of the polystyrene surface 
(Folkman and Moscona 1978).  
     Although using polyHEMA coated plates enhances spheroid generation as well as 
being cost effective, this method has some limitations where it is difficult to control the 
size of the spheres, and it is important to insure a homogenous coating of polyHEMA 
(Ke, Albers et al. 2004).  Where uneven coating occurs, this may result in poor ethanol 
evaporation and/or impurities in the PolyHEMA will affect the formation of the spheroids 
(Atala and Lanza 2001).  
     In the present study the viability and hence proliferation was assessed using the MTT 
assay that measures viable cells through their mitochondrial enzyme activity (Cree 2011). 
Cell growth in vitro is dictated by three main factors including cell type, cytokine/growth 
factor environment, and material related factors (Stachowiak 2010). Therefore cell growth 
and behaviour is affected since they are placed outside their natural environment into an 
artificial medium which usually comprises nutrients that helps cell growth and survival 
(Haycock 2011; Arora 2013). For that reason, replacing old media with new media effects 
cell viability and hence MTT levels will increase. Additionally, cell competition for 
nutrients and their interaction with each other plays a role, therefore viable cell numbers 
could decrease at a very high and low cell density over time. Overall, this explains the 
results in this study where MTT levels decreased after 7 days in some cases and by 21 
days in most cases studied. However at 28 days the viability of cells in most cases 
increases.  
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     On the other hand, β-glycerophospate, ascorbic acid, and dexamethasone were added 
to the media to induce osteogenesis (Martinez, Donato et al. 2012). β -glycerophosphate 
works as a source of inorganic phosphate for the mineralization process (Kaveh, Ibrahim 
et al. 2011). Whereas ascorbic acid is added as a cofactor for the enzyme that 
hydroxylates the proline residues in proteins [collagen], ensuring it folds correctly 
(Kaveh, Ibrahim et al. 2011). Dexamethasone is a synthetic glucocorticoid that enhances 
osteogenic, chondrogenic and adipogenic differentiation of MSC, upregulating alkaline 
phosphatase an early marker for bone (Wang, Pang et al. 2012).  In this chapter both the 
efficiency of spheroids generation and cell viability under osteogenic conditions were 
investigated. The results of this study showed that spheroids start to disintegrate in long 
term culture in osteogenic media. Dissociation  of spheroids may be due to mechanical or 
shear fluid force that are caused when changing the culture media (Debruyne, Mareel et 
al. 2009). However, this shouldn’t be the case since spheroids grown under normal 
conditions were compact and rigid indicating that it might be related to changing activity 
of the cells in response to the osteogenic media supplements. Previous studies showed 
that dexamethasone supplementation decreased cell proliferation and increased apoptosis 
(Kim, Kim et al. 2013). In contrast, other studies suggested that dexamethasone increases 
osteoprogenitor cell proliferation (Bellows, Heersche et al. 1990). Moreover, previous 
results on dexamethasone effects on apoptosis are contradictory where it depends on cell 
type, for example, adding it to lymphocytes, thymocytes and some tumour cells induced 
apoptosis, whilst in neutrophils and hepatocytes it was reduced (Song, Caplan et al. 
2009). However, it was also reported that the presence of dexamethasone in long term 
culture may have a toxic effect on cells and may cause cell lysis (Kaveh, Ibrahim et al. 
2011). Also it was reported that cells apoptosis increases at a higher cell density but the 
effect is diminished in a medium that contains 100nM of dexamethasone (Song, Caplan et 
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al. 2009). So, overall the type of cell line, the concentration of dexamethasone, and period 
of cell culture play a role on cell viability and spheroid dissociation due to cell death. 
Interestingly, the MTT assay shows that the viability of cells increased after 21 days. The 
reason for this is not clear but it may have something to do with cell line used in this 
study and/or changing old with new media.   
 
     We also measured the diameter and counted the number of spheroids formed. The 
findings observed in this study support those of the previous studies which showed an 
increase in the size of spheroids over time  (Jing and Jian-Xiong 2011). A possible 
explanation for this might be due to spheroids gathering together increasing the size and 
decreasing the number of spheroids at the same time. This gathering may be caused by 
the movements of the spheres when observing and/or changing media. Changing media 
also may cause the loss of spheroids which may explain the reduction of spheroid 
number.  
  
     In conclusion, although some previous studies showed success in generating spheroids 
diverse cell lines behave differently the work presented here suggests that coating the 
surface of the well plate with Poly-HEMA is considered as the most reproducible way to 
develop spheroids in culture that can be studied over several weeks. In this chapter only 
the efficiency of spheroids and viability were examined, although it may be worth 
investigating alkaline phosphatase levels as well in the future.  
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Chapter 4: Investigating cell gene expression and communication in 2D 
and 3D cultures 
 
4.1 Introduction: 
     Bone homeostasis and structural maintenance is controlled by cellular communication 
(Edwards and Mundy 2008). Whilst soluble mediators and immobilised growth factors 
and cytokines play a hugely significant role in coordinating cell activity, direct cell-cell 
interactions such as those formed by gap junctions are equally important.  Connexin 43 
[Cx43] is a gap junction protein that is expressed abundantly by bone cells including 
osteocytes, osteoblasts, and osteoclasts, where it plays an important role in cell-cell 
communication (Plotkin and Bellido 2013). Previous studies reported an up-regulation of 
Cx43 during fracture healing supporting its role in bone formation (Loiselle, Paul et al. 
2013).  Gap junctions also interact with other cell-cell structures including Eph/ephrin 
signalling in cells (Arvanitis and Davy 2008). Bone cells express ephrin B1, ephrin B2, 
Eph B2, Eph B3, Eph B4,  Eph B6,  and Eph A4 (Xing, Kim et al. 2010). Ephrin B2 is 
reported to be upregulated at sites of bone injury (Benson, Opperman et al. 2012). In 
addition, treating cells in vitro with ephrin B2 increases osteoblastic genes such as ALP, 
and osterix (Zhao, Irie et al. 2006).  
 
      The objective of this part of the study was to evaluate the expression of genes that are 
associated with cell-cell interaction in bone namely ALP, Runx2, osterix, ephrin B1, 
ephrin B2, ephrin B4, and Cx43; and furthermore identify how cell growth in 2D and 3D 
under normal and osteogenic conditions influences the regulation of these genes.  
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4.2 Materials and methods: 
All materials and reagents were purchased from Sigma-Aldrich company, Ltd Ayrshire, 
UK unless otherwise specified.  
4.2.1 Cell culture 
     Tissue culture was carried out in an aseptic environment using a class II laminar flow 
hood. Cells were grown as monolayer [2D] and as suspension [3D] using plates coated 
with polyHEMA. 
4.2.1.1Poly-HEMA stock solution:  
     PolyHEMA stock solution was prepared as previously described in section 3.2.1.2. 
4.2.1.2 Preparation of Poly-HEMA Coated Plates: 
     The plate wells were coated with PolyHEMA following the method in section 3.2.2.2. 
4.2.1.3 Rat calvarial cell culture: 
     Rat cells culture was carried out following sections 2.1.1., 3.2.2.1. 
4.2.1.4 Human mesenchymal stem cells cell culture: 
     Human mesenchymal stem cells were purchased from Lonza and cultured as described 
previously in sections 2.1.1 but using Dulbecco’s Modified Eagle’s Medium - low 
glucose.  
4.2.2 Histology and immunoflourescent studies: 
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4.2.2.1 Hematoxylin and eosin staining:  
     Samples were prepared and stained with standard Hematoxylin and eosin stain as 
described previously in section 2.1.8.1. 
4.2.2.2 Immunofluorescent staining:  
     Immunolocalization of CX43 was performed as described previously in section 
2.1.8.2. Samples that had been embedded in wax were deparaffinised using xylene for 
3m, rehydrated in 100% then 98% ethanol for 3min each, then underwent antigen 
retrieval as described in section 2.1.8.2.  (Mayer, Walker et al. 1988).  
4.2.3 Scanning electron microscopy [SEM]: 
     To examine spheroid structure and morphology samples were prepared as described 
previously section 2.1.7. 
4.2.4 Evaluation of cell viability and proliferation using MTT assay: 
     Cells viability was performed as described in sections 2.1.3 and 3.2.2.3. 
4.2.5 Alkaline phosphatase assay:  
      Osteoblastic differentiation of both cell lines was assessed by measuring alkaline 
phosphatase activity following the method outlined in section 2.1.4. 
4.2.6 RNA isolation and quantitative real time polymerase chain 
reaction:  
     The expression of mRNA levels for genes associated with osteogenesis, including 
Runx2, ALP, osterix and osteocalcin were determined using a quantitative real time 
polymerase chain reaction [qPCR].  Methodology was followed as previously described 
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in section 2.1.6. The cycle threshold [Ct] values were normalized against the house 
keeping gene GAPDH.  
 
 
4.2.7 Statistical analysis: 
     Data management and analysis was performed using SPSS 19.0. [SPSS Inc., USA]. 
Data were first explored to verify if they were normally distributed with a p value above 
0.05 using Shapiro-Wilk’s test to indicate a normally distributed data (Shapiro and Wilk 
1964; Razali and Wah 2011). The data histograms, normal Q-Q plots which determine if 
two data sets come from a population with a common distribution, and box plots to 
identify outliners and compare distributions were also inspected visually.  Since the 
analysis showed that some of the data were normally distributed while others were not 
normally distributed parametric and non- parametric methods were used respectively. In 
the former case a one way analysis of variance [ANOVA] was conducted to determine if 
there are any significant differences between the means, the variance was then subjected 
to a Post-hoc analysis with Bonferroni to determine which means differ. In case of non-
Gaussian distributed data, a Kruskal-Wallis analysis of variance was conducted. The 
variance was then subjected to a multi-comparison analysis Mann – Whitney U test with 
Bonferroni correction to determine the significance. Data were considered statistically 
significant when p value ≤ 0.05. 
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4.3 Results: 
 
 
4.3.1 Connexin 43 localisation in 2D and 3D culture: 
 
     To visualize Cx43 gap junctions, samples were stained with anti-Cx43 antibody. As 
shown in Figure 4.1, Cx43 was localized around the nucleus and the membrane in cells 
grown in normal media on tissue culture plastic. While those grown in osteogenic media 
showed more Cx43 at cell-cell contact regions [figure 4.2]. However using conventional 
epifluorescence microscopy, in 3D cell culture it was hard to visualize Cx43 compared to 
2D culture [figure 4.3 and 4.4] although Cx43 was seen in the centre of some spheroids 
[figure 4.3]. Therefore, confocal microscopy was used where an x,y,z series of  images 
could be obtained throughout the thickness of the sample. This approach allowed Cx43 to 
be localised in each layer of the spheroid. In early attempts we used a normal microscope 
slide, but this caused flattening of the cell aggregates. So, a concave slide was used in 
order to retain the original spherical shape of the spheroids.  As seen in Figure 4.7 and 4.8 
I was able to maintain the spherical structure, however, I was unable to localize Cx43 as 
observed in 2D.  Subsequently, collodion bags were used and the spheroids were 
sectioned and stained first with a routine H & E stain [figure 4.9]. Some sections were 
then de-waxed and stained with antiCx43 antibody to check if it was possible to localize 
Cx43 and it was difficult to do so.    
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 Figure 4.1: Immunofluroescent staining of Cx43 in rat calvarial cells monolayers grown for 7 
days under normal conditions. Cx43 [green] localize around the nucleus [blue] and at the cell 
membrane  
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Figure 4.2: Immunofluorescent staining of Cx43 in rat calvarial cells monolayers grown for 7 days 
under osteogenic conditions. Cx43 [green] localize at the cell membrane  
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Figure 4.3: Immunofluorescent staining of Cx43 in rat calvarial cells 3D grown for 7 days (a) 
Normal media (b) osteogenic media. Cx43 [green] while nucleus is stained with DAPI [blue] 
(a) 
(b) 
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(a) 
 
Figure 4.4: Immunofluorescent staining of Cx43 in human mesenchymal stem cells 3D grown for 7 
days (a) Normal media (b) osteogenic media. Cx43 [green] while nucleus is stained with DAPI [blue] 
 
(b) 
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Figure 4.5: laser confocal images of Cx43 in rat calvarial cells 3D grown for 7 days (a) Normal 
media (b) osteogenic media. Cx43 [green] while nucleus is stained with DAPI [blue] 
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Figure 4.6: laser confocal images of Cx43 in human mesenchymal stem cells 3D grown for 7 days             
(a) Normal media (b) osteogenic media. Cx43 [green] while nucleus is stained with DAPI [blue] 
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Figure 4.7: Laser confocal microscopy series of images of a spheroid. [a-o] images of Cx43 localization 
[green] while [1-15] are images of the cell nuclei stained with DAPI [blue] 
 
 
 
(a) (b) (c) (d) (e) 
(i) (j) (f) (g) (h) 
(n) (o) (k) (l) (m
) 
(4) (5) (1) (2) (3) 
(9) (10) (6) (7) (8) 
(14) (15) (11) (12) (13) 
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Figure 4.8: A Z -section confocal microscope image of spheroids placed on a concave slide in 
order to maintain the spherical shape of the sphere, spheroid thickness in (a) 52.2µm and (b) 
97.49µm  
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Figure 4.9: Hematoxylin and Eosin [H&E] stain of a spheroid section cultured for 7 days; nucleus 
[dark purple] and cytoplasm [light purple] (a) lower and (b) higher magnification 
 
(b) 
 
(a) 
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Figure 4.10: Immunofluorescent analysis of Cx43 [green], the spheroid section stained with 
antiCx43 antibody (a) nucleus stained [blue] using DAPI (b) Cx43 
 
(a) 
 
(b) 
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4.3.2 Morphological analysis of spheroids:  
 
     Scanning electron microscopy (SEM) was used to obtain high resolution structural 
images of spheroids. Two technical approaches were investigated to prepare the samples, 
first, spinning the spheroids at a low speed to from a pellet. The second was to collect the 
spheroids gently using a pipette tip.  
In Figure 4.11 it can be seen that using the centrifugation approach the sphere shape was 
deformed as collected by pellet method, unlike the collection method where they 
maintained their spherical shape. After 24hrs the spheroids begin to form more irregular 
shapes which may be caused by small spheres merging to larger ones under both normal 
and osteogenic culture conditions [Figures 4.12 and 4.13]. Also, communication between 
spheroids was noted [see Figure 4.12]. After 7days of culture the spheres appeared 
compact and solid when grown under normal conditions [Figure 4.14]. While those 
maintained under osteogenic conditions formed spheroids that were much looser and in 
fact started to dissociate [Figure 4.15].  On the other hand, SEM images of human 
mesenchymal stem cells spheroids revealed that they were more compact compared to 
calvaria cells, for those grown after 24hr and 7days and in both normal and osteogenic 
media [ see figures 4.16 and 4.17] 
     It is worth mentioning here that spheroids must be placed in another well plate before 
starting the processing for SEM. If not, this will cause the formation of amorphous 
substance at the surface of the spheres caused by polyHEMA dissolved from the well 
surface [Figure 4.18].  
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Figure 4.11:  SEM image of rat calvarial cell spheroids where they lose their spherical shape with 
no differences between both those grown in normal and osteogenic media (a) normal media (b) 
osteogenic media 
 
(a) 
(b) 
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(a) 
 
(b) 
 
(c) 
 
Figure 4.12:  SEM image of rat calvarial cells spheroids after 24hr grown in normal 
media (a) lower magnification (b) and (c) higher magnification illustrates 
communication [intracellular filopedia] between spheroids  
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Figure 4.13:  SEM image of rat calvarial cells spheroids after 24hr grown in osteogenic media (a) 
lower and (b) higher magnification illustrates small spheres in contact with a larger sphere 
 
 
(a) 
 
(b) 
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Figure 4.14:  SEM image of rat calvarial cells spheroids at 7days grown in normal media (a) lower 
and (b) higher magnification illustrates a compact sphere 
 
(a) 
 
(b) 
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Figure 4.15:  SEM image of rat calvarial cells spheroids at 7days grown in osteogenic media (a) 
lower and (b) higher magnification illustrates spheres that dissociate  
 
(a) 
 
(b) 
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Figure 4.16:  SEM image of human mesenchymal stem cells spheroids after 24hr grown in (a) 
normal media and (b) osteogenic media 
 
(a) 
 
(b) 
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Figure 4.17:  SEM image of human mesenchymal stem cells spheroids at 7days grown in (a) 
normal media and (b) osteogenic media 
 
(a) 
 
(b) 
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Figure 4.18:  SEM image of spheroids with amorphous coating believed to be polyHEMA from the 
surface of the culture plates  
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4.3.3 Cell Viability in 2D and 3D: 
     Cell viability and proliferation was assessed using an MTT colorimetric assay.    The 
MTT assay showed that cell number grown as monolayer are higher than those grown as 
3D culture in both cell lines. After 24hr cells grown in 2D with normal culture media 
were more abundant than those grown under osteogenic conditions [Figure 4.19 and 
4.20].  However, the viability of the cells grown in 3D under routine and osteogenic 
conditions was almost equal [Figures 4.19 and 4.20].  
    At 72hrs the viability of cells grown in 3D culture decreased, while the viability of 
those grown in 2D increased [figure 4.21 and 4.22]. The cell number at 7 days in cells 
grown in normal media in 2D remained elevated compared to those grown in osteogenic 
media [Figure 4.23 and 4.24]. In contrast, the viability of cells in 3D decreased with a 
slight reduction between cells in normal and osteogenic media [Figure 4.23 and 4.24]. 
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Figure 4.19 Graph shows the viability of calvarial rat cells after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media. 
 
* * 
Figure 4.20 Graph shows the viability of human MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media. 
 
* 
* * 
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Figure 4.21 Graph shows the viability of rat calvarial cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media. 
 
 
* * 
Figure 4.22 Graph shows the viability of human MSCs at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media. 
 
 
* 
* 
* 
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Figure 4.23 Graph shows the viability of rat calvarial cells at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media. 
 
 
* 
* * 
Figure 4.24 Graph shows the viability of human MSCs at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media. 
 
 
* 
* * 
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4.3.4 Alkaline phosphatase assay:  
     The alkaline phosphatase assay was performed to assess osteogenic differentiation of 
rat and human cells in both 2D and 3D culture.  
     Data showed that after 24hr there was no significant difference in the ALP activity in 
rat cells grown in 2D compared to those in 3D [Figure 4.25]. Though, the expression of 
the ALP enzyme differs significantly in human MSCs between both grown under normal 
and osteogenic conditions [Figure4.26]. At 72hr the enzyme expression increased in cells 
grown in 2D and under osteogenic conditions compared to those in normal media in rat 
cells but with no significant differences.  While in MSCs the expression of the enzyme 
increased in osteogenic media in 2D, but remains almost the same in normal media 
[Figure 4.26]. In contrast, MSCs in a 3D culture enzyme activity was almost the same in 
osteogenic media with a slight decrease in normal media [Figure 4.26].  
     In comparison, at 7 days the ALP enzyme activity of calvarial cells interestingly 
increased slightly in normal media rather than osteogenic media [Figure 4.29]. However, 
in 2D MSCs the ALP level decreased in cells grown in normal media with a slight 
decrease in 3D, while it increased slightly in those grown in osteogenic media [Figure 
4.30]. 
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Figure 4.25 Graph shows the alkaline phosphatase activity level of rat calvarial 
cells after 24hr, the Data represents the mean ± standard error of the mean n=9, a 
statistical significant was considered when P value ≤ 0.05, no significant were seen 
after 24 hr 
 
Figure 4.26 Graph shows the alkaline phosphatase activity level of human MSCs 
after 24hr, the Data represents the mean ± standard error of the mean n=9, a 
statistical significant was considered when P value ≤ 0.05 where (*) indicates 
significance compared to 2D normal media 
 
* 
* 
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* 
Figure 4.27 Graph shows the alkaline phosphatase activity level of rat calvarial 
cells at 72hr, the Data represents the mean ± standard error of the mean n=9, a 
statistical significant was considered when P value ≤ 0.05, as 24hr no significant 
were seen here as well 
 
Figure 4.28 Graph shows the alkaline phosphatase activity level of human MSCs at 
72hr, the Data represents the mean ± standard error of the mean n=9, a statistical 
significant was considered when P value ≤ 0.05 05 where (*) indicates significance 
compared to 2D normal media 
 
 
* 
* 
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Figure 4.29 Graph shows the alkaline phosphatase activity level of rat calvarial 
cells at 7days, the Data represents the mean ± standard error of the mean n=9, a 
statistical significant was considered when P value ≤ 0.05 where (*) indicates 
significance compared to 2D normal media 
 
 
* 
Figure 4.30 Graph shows the alkaline phosphatase activity level of human MSCs at 
7days, the Data represents the mean ± standard error of the mean n=9, a statistical 
significant was considered when P value ≤ 0.05 where (*) indicates significance 
compared to 2D normal media 
 
 
* 
* 
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4.3.5 Changes in gene expression between 2D and 3D culture: 
     Quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR) 
analysis was conducted to compare the relative expression of osteogenic genes in cells 
grown in 2D and 3D culture under different media conditions. The mRNA transcripts 
investigated in this study included ALP, Runx2, SP7, Cx43, EphrinB1, Ephrin B2, and 
Ephrin B4. 
     After 24hr calvarial cells grown on tissue culture plastic in normal media 
demonstrated a significantly higher expression of ALP compared to those grown in 
osteogenic media and 3D culture cells in normal and osteogenic media [Figure 4.31].  
Similarly, MSCs in 2D culture osteogenic media showed a higher ALP expression 
compared to 2D normal and 3D normal and osteogenic media [Figure 4.32]. In addition, 
ALP expression showed no significant difference between 2D culture of cells grown in 
normal media and 3D cells grown in normal and osteogenic media [Figure 4.32]. 
     However at 72hr ALP expression increased significantly in cells grown in osteogenic 
media as monolayers for both rat calvarial and human MSCs [Figure 4.33 and 4.34].  
      Interestingly, at 7days the ALP level decreased in calvarial cells grown in osteogenic 
media while it increased in cells grown in normal media [Figure 4.35].  In comparison, 
ALP increased significantly in MSCs grown in osteogenic media as monolayers 
compared to cells in 2D normal media and 3D normal and osteogenic media [Figure 
4.36].  
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Figure 4.31 ALP relative level expression in rat calvarial cells after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
 
 
* 
* 
* 
* 
Figure 4.32 ALP relative level expression in MSCs after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05, as shown in the graph no significance were seen. 
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Figure 4.33 ALP relative level expression in rat calvarial cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
 
 
* 
* 
* 
Figure 4.34 ALP relative level MSCs at 72hr, the data represents the mean ± 
standard error of the mean n=9, a statistical significant was considered when P 
value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
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Figure 4.35 ALP relative level Rat cells at 7days, the Data represents the mean ± 
standard error of the mean n=9, a statistical significant was considered when P 
value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
Figure 4.36 ALP relative level MSCs cells at 7days, the Data represents the mean ± 
standard error of the mean n=9, a statistical significant was considered when P 
value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
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      After 24hrs rat cells grown in 2D normal media showed a significantly higher Runx2 
expression compared to cells grown in osteogenic media.  In contrast, those grown in 3D 
culture showed a significantly higher expression when grown in osteogenic media [Figure 
4.37].  MSCs grown on tissue culture plastic in osteogenic media showed a higher Runx2 
expression with significant difference compared to 2D normal media and 3D normal and 
osteogenic media [Figure 4.38] 
     At 72hrs Runx2 expression was significantly increased in both cell types for those 
grown in osteogenic media as a monolayer compared to 2D normal media and 3D normal 
and osteogenic media [Figure 4.39] and [Figure 4.40].  
     At 7days Runx2 expression in rat cells decreased in both cells grown in normal and 
osteogenic media, while the expression increased significantly in cells grown in 3D 
normal media compared to osteogenic media [Figure 4.41]. MSCs Runx2 expression 
remained almost the same in 2D and 3D osteogenic and normal media respectively, 
though it decreased in 2D and 3D normal and osteogenic media respectively [Figure 
4.42]. 
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Figure 4.37 RUNX 2 relative level expression in rat cells after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when    P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
Figure 4.38 RUNX 2 relative level expression in MSCs after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when    P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
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Figure 4.39 RUNX 2 relative level expression in rat cells at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when     P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
Figure 4.40 RUNX 2 relative level expression in MSCs at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
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Figure 4.41 RUNX 2 relative level expression in rat cells at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when   P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
  
 
* 
* 
* 
Figure 4.42 RUNX 2 relative level expression in MSCs at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
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      Osterix or SP7 gene expression was high after 24hr in 2D and 3D calvarial cells grown 
in normal media compared to those under osteogenic conditions [Figure 4.43]. Osterix 
expression decreased significantly at 72 hrs in 2D normal media with a significant 
increase in 2D osteogenic media. There was a slight increase in cells grown in 3D under 
normal and osteogenic media [Figure 4.45].  At 7days the SP7 gene expression continues 
to decrease in both cells grown in 2D and 3D and in both media conditions compared to 
24hr and 72hr [Figure 4.47].  
    On the other hand human MSCs SP7 gene expression levels were very low compared 
to calvarial cells. After 24hr of cells seeding the expression level of the gene was 
significantly higher in monolayer cells grown in osteogenic media compared to 2D 
normal and 3D normal and osteogenic media [Figure 4.44].  Nonetheless, SP7 expression 
increased significantly in all cells grown in 2D and 3D culture and under both normal and 
osteogenic media at 72hr. Surprisingly at 7 days the level of the gene in cells grown in 3D 
under osteogenic media increased significantly with a slight increase in 2D normal and 
osteogenic media and in 3D normal media [Figure 4.48].  
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Figure 4.44 SP7 relative level expression in MSCs after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* * 
* 
Figure 4.43 SP7 relative level expression in rat cells after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
  
 
* 
* 
* 
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Figure 4.45 SP7 relative level expression in rat cells at 72hr, the data represents the 
mean ± standard error of the mean n=9, a statistical significant was considered 
when     P value ≤ 0.05 where (*) indicates significance compared to 2D normal 
media 
 
 
* 
* 
* 
Figure 4.46 SP7 relative level expression in MSCs at 72hr, the data represents the mean 
± standard error of the mean n=9, a statistical significant was considered when                      
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
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* 
Figure 4.47 SP7 relative level expression in Rat cells at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
  
 
Figure 4.48 SP7 relative level expression in MSCs at 7days, the data represents the 
mean ± standard error of the mean n=9, a statistical significant was considered 
when     P value ≤ 0.05 where (*) indicates significance compared to 2D normal 
media 
 
 
* 
* 
* 
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        After 24hrs a significantly higher level of Cx43 gene expression was detected in 
calvarial cells grown in normal media as monolayers [Figure 4.49]. Whereas no 
significant different was detected in Cx43 expression in MSCs grown under normal and 
osteogenic media in both 2D and 3D culture [Figure 4.50].  
     Conversely at 72hr, Cx43 expression raised in monolayers grown in osteogenic media 
and decreased in normal media [Figure 4.51].  Nevertheless, Cx43 levels decreased in 
cells grown in normal and osteogenic media in 3D culture [Figure 4.51].  In contrast, 
MSCs showed a significant increase in Cx43 expression in cells grown under osteogenic 
conditions in both 2D and 3D culture [Figure 4.52]. Also, a significant increase in the 
Cx43 transcript abundance was observed in 3D culture grown in normal media compared 
to 2D [figure 4.52].  
     Interestingly, Cx43 expression at 7 days increased again in 2D cultured cells in normal 
media and decreased in cells grown in osteogenic media [Figure 4.53].  This was 
accompanied by an approximately similar level of gene expression in 3D culture [Figure 
4.53].  Cx43 expression continued to rise in MSC monolayers grown in osteogenic media 
and strikingly rise in 3D cells grown in normal media where the gene expression 
approximately at the same level as 2D osteogenic media [figure 4.54].  Though, a 
significant decrease in Cx43 level in 3D cells grown in osteogenic media was observed 
with a slight decrease in 2D cells grown in normal media [Figure 4.54].  
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Figure 4.50 CX43 relative level expression in MSCs after 24hr, the data represents the 
mean ± standard error of the mean n=9, a statistical significant was considered when           
P value ≤ 0.05. No significant were seen here.  
 
 
Figure 4.49 CX43 relative level expression in rat cells after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when   P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* * 
* 
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Figure 4.51 CX43 relative level expression in rat cells at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
  
 
* * 
* 
Figure 4.52 CX43 relative level expression in MSCs at 72hr, the data represents the 
mean ± standard error of the mean n=9, a statistical significant was considered 
when     P value ≤ 0.05 where (*) indicates significance compared to 2D normal 
media 
  
 
* 
* * 
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 Figure 4.53 CX43 relative level expression in rat calvarial cells at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
 
 
 
* 
* 
* 
Figure 4.54 CX43 relative level expression in MSCs at 7days, the data represents the 
mean ± standard error of the mean n=9, a statistical significant was considered when         
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
* * 
* 
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        After 24hrs ephrin B1 expression was significantly higher in 2D rat cells grown in 
normal media compared to 2D grown in osteogenic media and 3D culture [Figure 4.55]. 
Whereas the level of the transcript abundance in MSCs was significantly higher in 2D and 
3D cells under osteogenic and normal conditions respectively [Figure 4.56].  
     At 72hrs, a significant increase in ephrin B1 expression in 2D rat cells under 
osteogenic conditions was observed with a significant decrease in those grown under 
normal conditions [Figure 4.57]. There was a decrease in ephrin B1 expression in 3D 
cells grown in normal media [Figure 4.57].  After 72 hrs the gene expression in MSCs 
increased significantly in 2D and 3D cells grown in normal and osteogenic media 
compared to cells grown after 24hr. There was a significant increase in the gene 
expression in 2D cells grown in osteogenic media compared to normal media [Figure 
4.58].  There was a high level of the gene detected in 3D culture with a similar level in 
both grown in normal and osteogenic media [Figure 4.58].  
      At day 7 the transcript abundance decreased significantly in cells grown in 2D and 3D 
in normal and osteogenic media compared to 24hr and 72hr [Figure 4.59]. Whereas, 
MSCs 2D gene level grown in osteogenic media continued significantly to rise [Figure 
4.60]. 
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Figure 4.55 Ephrin B1 relative level expression in rat calvarial cells after 24hr, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
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Figure 4.56 Ephrin B1 relative level expression in MSCs after 24hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when    P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
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Figure 4.57 Ephrin B1 relative level expression in rat cells at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when       
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
  
 
* 
* * 
Figure 4.58 Ephrin B1 relative level expression in MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
 
 
* * 
* 
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Figure 4.59 Ephrin B1 relative level expression in rat cells at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when      P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
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Figure 4.60 Ephrin B1 relative level expression in MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
 
 
* 
* 
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        After 24hrs a significantly high level of ephrin B2 gene expression was observed in 
2D cells grown in normal media in comparison with those grown in osteogenic media and 
3D cells grown in both normal and osteogenic media [Figure 4.61]. While in MSCs both 
2D and 3D cells grown in normal media showed an approximately similar level of gene 
expression [Figure 4.62]. In addition, approximately equivalent expression was detected 
in 2D and 3D cells grown in osteogenic media [figure 4.62].  
      A significant decrease in gene level was detected in 2D rat cells grown in normal 
media; conversely, a significant increase was identified cells grown in 2D in osteogenic 
media for 72hr [Figure4.63]. While MSCs showed a significantly higher expression in 2D 
under both media conditions [Figure 4.64] there was a decrease in 3D culture under both 
media conditions [Figure 4.64].  
     At 7 days, a significantly lower level of ephrinB2 transcripts was observed in 2D rat 
cells with increase in cells grown in normal media and approximately similar expression 
in 3D cells grown at 24 and 72hrs [Figure 4.65].  Under osteogenic conditions, the gene 
expression levels continued to increase significantly in 2D and 3D conditions in MSCs 
[Figure 4.66].  
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Figure 4.61 Ephrin B2 relative level expression in rat cells after 24hr, the Data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to 2D 
normal media 
 
 
* * 
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Figure 4.62 Ephrin B2 relative level expression in MSCs after 24hr, the Data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when        
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* * 
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Figure 4.63 Ephrin B2 relative level expression in rat cells at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when        
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
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Figure 4.64 Ephrin B2 relative level expression in MSCs at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
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Figure 4.65 Ephrin B2 relative level expression in rat cells at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when       
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* * 
Figure 4.66 Ephrin B2 relative level expression in MSCs at 7days, the data represents the 
mean ± standard error of the mean n=9, a statistical significant was considered when              
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
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        After 24hrs a significantly higher level of ephrin B4 gene expression was detected in 
2D rat cells grown in normal media compared to those grown in osteogenic media and 
those 3D cultures grown in normal and osteogenic media [Figure 4.67]. While MSCs 
showed a significantly high level gene expression in 2D cells grown under osteogenic 
conditions [Figure 4.68].  
     Unlike cells grown for 24hr, at 72hrs higher ephrin B4 expression was detected in 2D 
cells grown in osteogenic media with a significant low level in 2D cells grown in normal 
media [Figure 4.69].  A decrease in gene expression was also detected in 3D cultures 
grown in normal media [Figure 4.69].  Whereas a significant increase in ephrin B4 
transcript levels was detected in 2D and 3D cultures under both media conditions, it was 
also noted that both 2D and 3D culture under osteogenic conditions scored similarly 
[Figure 4.70].  
      At 7days, strikingly the level of the gene decreased significantly in 2D cells grown 
under osteogenic media, and significantly increased in 2D cells in normal media while 
approximately no noticeable change to the level of the gene was observed in 3D cultures 
[Figure 4.71].  MSCs showed a slight decrease in ephrin B4 expression in 2D and 3D 
cultures in both media compared to those grown at 72hr [Figure 4.72].  
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Figure 4.67 Ephrin B4 relative level expression in rat cells after 24hr, the Data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when 
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
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Figure 4.68 Ephrin B4 relative level expression in MSCs after 24hr, the Data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when       
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
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Figure 4.70 Ephrin B4 relative level expression in MSCs at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when     P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* * 
* 
Figure 4.69 Ephrin B4 relative level expression in rat cells at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when       
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
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Figure 4.71 Ephrin B4 relative level expression in rat cells at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered when          
P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
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Figure 4.72 Ephrin B4 relative level expression in MSCs at 7days, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered 
when     P value ≤ 0.05 where (*) indicates significance compared to 2D normal media 
 
 
* 
* 
* 
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4.4 Discussion:  
    Cx43 is a key component in bone cells signalling where it plays a vital role in bone 
cells proliferation, differentiation, and survival (Loiselle, Paul et al. 2013). In previous 
studies, Cx43 expression level and localization was found to correlate with the gap 
junction protein phosphorylation where Cx43 hyperphosphorylation indicates an increase 
of Cx43 in the cell membrane while a reduction of Cx43 localization in the membrane 
was coupled with Cx43 hypophosphorylation (de Feijter, Matesic et al. 1996). Moreover, 
it was found that Eph/ephrin signalling inhibits gap junction (Arvanitis and Davy 2008). 
Where ephrin B1 was reported to disrupt the distribution of Cx43 preventing it from 
forming a functional gap junction at the cell membrane and thus affecting cells 
communication (Gross 2006).  
     In this study the expression and localization of Cx43 were examined. Results showed 
that in cells grown in monolayer at 7days; in most of the cells Cx43 localized around the 
nucleus under normal conditions indicating an increase of Cx43 hypophosphorylation. 
While in osteogenic media, Cx43 was localized at the cell surface in contact with other 
cells indicating an increase of Cx43 hyperphosphorylation. A high expression of Cx43 
over time is expected as the SEM images of the results showed more compact spheres at 
7days.   
     In 3D culture the fluorescent microscopy images were not clear although Cx43 was 
spotted, but even with the use of confocal microscopy it was hard to identify Cx43 
junctions. Previously it was noted the challenges of obtaining a high resolution images in 
3D culture systems (Pampaloni, Reynaud et al. 2007; Mueller-Reichert 2010). 
     On the other hand, both Cx43 and ephrin B1 transcript levels were high in cells grown 
in normal media at 7days.  A high level of ephrin B1 may explain the reason for Cx43 
perinuclear localization ephrin B1 inhibits Cx43 gap formation in the cell membrane. The 
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mechanism by which ephrins signalling inhibits Cx43 gap junction is still unclear 
(Arvanitis and Davy 2008).   
      Another key component in bone cells is Runx2 which has been identified as the 
master gene that controls osteoblasts differentiation (Shui, Spelsberg et al. 2003). Runx2 
expression is higher at the early stages of osteogenesis and in particular by pre-
osteoblasts/immature osteoblasts and the expression is down regulated in mature 
osteoblasts (Choi 2012). Runx2 regulates both osteoblast proliferation and differentiation 
and promotes osteoblast maturation (Pratap, Galindo et al. 2003). Furthermore, the 
expression of bone matrix protein genes, mineralization, and  alkaline phosphatase 
activity is induced by Runx2 in both immature MSCs and osteoblastic cells in vitro 
(Fujita, Azuma et al. 2004). Another factor that directs the fate of mesenchymal cells 
towards osteogenesis is SP7 which is known also as osterix (Choi 2012). Osterix function 
during osteoblasts differentiation is not fully understood but it is induced by Runx2 
overexpression (Matsubara, Kida et al. 2008; Haycock 2011). However, previous studies 
have reported an osteogenic activity by osterix in Runx2 deficient MSCs suggesting that 
either osterix functions distinct from Runx2 or it works downstream of Runx2 
(Matsubara, Kida et al. 2008). Moreover, osterix expression increases when cells are 
treated with ephrin B2 and a rise in other osteoblastic genes including ephrin B1, alkaline 
phosphatase, osteocalcin, and collagen type1 (Benson, Opperman et al. 2012; Shaohong, 
Chandrasekhar et al. 2013).  
      The qRT-PCR results of this study demonstrated an up-regulation of Runx2 in both 
2D calvarial cells and 3D MSCs grown under normal and osteogenic conditions 
respectively. The findings of the current study are consistent with those of (Fujita, Azuma 
et al. 2004) who found that Runx2 induces ALP activity. Additionally, Runx2 
upregulation was accompanied by an increase in osterix, ephrin B1, ephrin B2, and ephrin 
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B4. In accordance with the present results, previous studies have demonstrated an 
increase in osterix expression via Runx2 (Matsubara, Kida et al. 2008).  Osterix also is 
regulated by ephrin B1 thus increases the level of both gene expressions (Xing, Kim et al. 
2010).  Also, previous research reported that ephrin B4 receptor is activated by ephrin B2 
gene expression (Kwan Tat, Pelletier et al. 2008).  
      Interestingly a high level of transcripts for genes that play a role in osteogenesis was 
observed in MSCs grown under osteogenic media, whereas in calvarial cells the 
expression was higher when grown in normal media. These results may be explained by 
the fact that calvarial cells contain a subpopulation of osteoprogenitors also known as 
preosteoblasts (Kadono, Kido et al. 1999). While MSCs are a multipotent stromal cells 
that can give rise to different cell lineages (Abdi, Fiorina et al. 2008).  
      Overall, the results suggest that growing MSCs under osteogenic media directs 
towards osteogenic differentiation regardless if they were grown in 2D or 3D culture. 
While rat calvarial cells are directed towards osteogenic differentiation under normal 
media regardless of if they were grown in 2D or 3D culture.  
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Chapter 5: In vitro osteogenic differentiation of cells encapsulated 
within a nanofiberous environment 
 
5.1 Introduction 
     Three dimensional biomaterials represent a promising tool in tissue engineering (Dvir-
Ginzberg, Gamlieli-Bonshtein et al. 2003). Hydrogels are one class of biomaterials that 
have been explored as scaffolds for tissue engineering applications (Drury and Mooney 
2003). These hydrogel scaffolds can be modified physically and chemically to adapt to 
the specific application, by altering parameters including surface morphology, shape, 
stiffness and porosity (El-Sherbiny and Yacoub 2013). Recently, the emergence of 
nanotechnology as a new efficient tool  in tissue engineering has identified nano-materials 
for biomedical applications (Zhang, Li et al. 2011). In particular a new type of 
biomaterial, the ionic self-complementary oligopeptides have been introduced  (Zhao and 
Zhang 2006).  
     RAD-16 also known commercially as Puramatrix is a self-assembly peptide which 
forms a hydrogel scaffold and designed by Zhang et al (Ozeki, Kuroda et al. 2011). 
Previous studies showed that using Puramatrix allows cells to proliferate and differentiate 
within a 3D environment (Zhang, Zhao et al. 2005).  
     The aim of the work presented here was to examine the effects of different hydrogel 
scaffolds (including Puramatrix) either presented on a surface or encasing the cells, on the 
cells viability and differentiation towards the osteoblast lineage.  
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5.2 Materials and methods: 
All materials and reagents were purchased from Sigma-Aldrich company, Ltd Ayrshire, 
UK unless otherwise specified.  
5.2.1 Cell culture 
     Tissue culture was carried out in aseptic environment using class II laminar flow hood. 
Cells were plated on the surface of the hydrogel and encapsulated within the hydrogel.  
5.2.1.1. Rat calvaria cell culture: 
Rat cells culture was carried out following methods represented in sections 2.1.1., 3.2.2.1. 
5.2.1.2 Human mesenchymal stem cells cell culture: 
     Human mesenchymal stem cells were purchased from Lonza and cultured as described 
previously in sections 2.1.1 but using Dulbecco’s Modified Eagle’s Medium - low 
glucose.  
5.2.2 Hydrogel scaffold preparation: 
5.2.2.1 Self-assembling peptide nanofibres: 
     Puramatrix peptide was purchased from BD Bioscience, the vial contained 5 ml of 1% 
[w/v] solution of purified peptide. The hydrogel scaffold was prepared following the 
manufacturers protocol. Briefly, the viscosity of the stock solution was decreased by 
vortexing or using a sonicator bath, and then to eliminate air bubbles - if present -
centrifugation was performed. Three different concentrations [0.1%, 0.25%, and 0.5%] of 
the peptide were prepared by diluting the stock solution with sterile water. For surface 
plating, 250µl of each concentration was plated on 24 well plate surfaces; 500µl of 
DMEM was then added slowly to promote gelation. The plates were then placed in the 
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incubator for 30-60 minutes depending on the peptide concentration, a higher 
concentration taking less time to form gel. The cell suspension was then added slowly and 
very carefully on top of the hydrogel. To achieve cell encapsulation a drop technique was 
used to resemble the formation of 3D spheroids. In this approach after decreasing the 
viscosity of the solution the concentrations were diluted with sterile 20% sucrose to 
generate 2x of the final desired concentration [figure 5.1]. After cell trypsinization the 
cells were collected by centrifugation and washed with sterile 10%(w/v) sucrose. Then, 
an equal volume of cell/sucrose mixture was combined with each concentration of 
Puramatrix/sucrose mixture. Then, multiple drops of 15µl of the cell/hydrogel mixture 
were placed alongside of the well plate containing media to initiate peptide self-
assembling. The plates were then placed in the incubator for 24hr, 72hr, and 7 days.  
 
  
 
 
 
 
 
 
 
 
5.2.2.2 Mussel adhesive protein: 
MAPTrix HyGel containing mussel adhesive protein coupled with collagen type1 peptide 
was purchased from Kollodis Bioscience. The hydrogel scaffold was prepared following 
the manufacturers protocol. In brief, the lyophilized protein [5mg/ml] was diluted with 
Figure 5.1: Flowchart of puramatrix hydrogel scaffold preparation (a) cells plating on the surface 
of the puramatrix (b) cells encapsulation using drop technique method 
 
Puramatrix + sterile 
dH2O 
Cells + sucrose  
Puramatrix 
(a) 
(b) 
143 
 
PBS to a final concentration of 2.0 wt% [w/v] solution. After that the MAPTrix linker 
[50mg/ml] [Kollodis Bioscience] was prepared by diluting with PBS to a final 
concentration of 3.0 wt% [w/v] solution. Then, an equal volume – 0.24ml for a 24 well 
plate – of both MAPTrix protein and MAPTrix linker were mixed and placed 
immediately on the well plate surface and once the hydrogel are formed cells were plated 
on top of the scaffold.  
 
5.2.3 Scanning electron microscopy [SEM]: 
     To examine the hydrogel surface with and without cells the samples were prepared as 
described previously in section 2.1.7. 
 
5.2.4 Evaluation of cell viability using the MTT assay: 
     To assess the viability of the encapsulated cells the MTT assay was performed. In 
brief, the cell/Puramatrix drops were mechanically disrupted by pipetting up and down in 
the well then transferred to a conical tube, the well was further washed with PBS and 
collected in the tube. After spinning for 5 minutes at low speed the supernatant was 
discarded and the pellet containing cells/Puramatrix was re-suspended in PBS. After 
centrifugation the pellet was collected for MTT assay as described in sections 2.1.3 and 
3.2.2.3. 
5.2.5 Alkaline phosphatase assay:  
      To assess osteoblastic differentiation cells were recovered as previously described in 
section 5.2.4. Then alkaline phosphatase activity was measured following the method in 
section 2.1.4. 
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5.2.6 RNA isolation and quantitative real time polymerase chain 
reaction:  
     The expression of mRNA levels of genes associated with osteogenesis including 
Runx2, ALP, osterix and osteocalcin were determined using a quantitative real time 
polymerase chain reaction [qPCR]. After recovering cells as previously described in 
section 5.2.4, RNA isolation and qRTPCR were carried out following method previously 
described in section 2.1.6. The cycle threshold [Ct] values were normalized against the 
house keeping gene GAPDH.  
 
 
5.2.7 Statistical analysis: 
     Statistical analysis was performed using SPSS 19.0. [SPSS Inc., USA]. Data were 
analysed as previously described in section 4.2.7.  
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5.3 Results: 
5.3.1 Morphological observations:  
    At first, cell interactions with the surface of the hydrogel scaffolds were assessed to 
understand the relationship between scaffold and cell morphology. Puramatrix scaffold 
was mechanically weak and fragile even at high concentrations and often failed to form a 
continuous layer of the surface of the tissue culture plates. As seen in Figures 5.2, 5.3, 
5.4, and 5.5 after 24hr and at 7days [Figures 5.6, 5.7, 5.8, and 5.9] due to the weak 
mechanical properties of Puramatrix hydrogel it broke away allowing cells to adhere to 
the surface of the well while others aggregated and formed clusters. Some of the cellular 
clusters can be seen communicating with each other’s as seen in figure [5.4].  
     On the other hand, MAPTrix hydrogel scaffold was morphologically stiffer compared 
to Puramatrix. After seeding cells on the surface of the scaffold the cells adhered to the 
surface and proliferated [Figures 5.10, and 5.11].  
     Studies were then performed to encapsulate the cells within the hydrogel in an attempt 
to create a model system that would allow us to understand how the balance between cell-
cell and cell-ECM signals can be used to influence cell fate and differentiation. A cell 
drop technique was used to create cell aggregates resembling the spheroids described in 
Chapter 4. As seen in Figure 5.12 the hydrogel drops at low concentration 0.1% were not 
firm compared to 0.2% and 0.5%. Under microscopic observation the 0.1% drops were 
homogenous in structural appearance unlike 0.2% and 0.5%, where at higher 
concentrations bubbles formed.  
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Figure 5.2:  Rat calvarial cells grown after 24hr on 0.1% Puramatrix in normal media, cells 
adhered [black arrows] while others formed clusters [red arrows] because of hydrogel breakage 
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Figure 5.3:  Rat calvarial cells grown after 24hr on 0.25% Puramatrix in normal media, cells 
formed clusters note the hydrogel breakage [black arrow]. 
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Figure 5.4:  Rat calvarial cells grown after 24hr on 0.5% Puramatrix in normal media, cells 
formed clusters [black arrow] and some communicated with each other [red arrow] 
(a) 
(b) 
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Figure 5.5:  Rat calvarial cells grown after 24hr on 1% Puramatrix in normal media, some cells 
formed clusters and some adhered to the hydrogel scaffold. The hydrogel is fragile though a high 
concentration was used.   
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Figure 5.6:  Rat calvarial cells grown at 7days on 0.1% Puramatrix in normal media, most of the 
cells adhered to the plate surface [black arrow] with few clusters [red arrow] 
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Figure 5.7:  Rat calvarial cells grown at 7days on 0.25% Puramatrix in normal media, most of the 
cells adhered to the plate surface [black surface] with few clusters [red arrow]  
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Figure 5.8:  Rat calvarial cells grown at 7days on 0.5% Puramatrix in normal media, most of the 
cells adhered to the plate surface [black arrow] with few cellular clusters contacting each other 
red arrow].  
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Figure 5.9:  Rat calvarial cells grown at 7days on 1 % Puramatrix in normal media, few cells 
adhering to the surface [black arrow] with cellular clusters [red arrow].  
 
154 
 
Figure 5.10:  Rat calvarial cells grown on MAPTrix hydrogel where cells adhered to the 
surface of the scaffold after 24hr [black arrow]  
 
155 
 
Figure 5.11:  Rat calvarial cells grown at 7days on MAPTrix hydrogel cells 
continue to grow on the surface of the scaffold [black arrow] 
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Figure 5.12: Shows drops of cells encapsulated within Puramatrix hydrogel [black arrow] grown 
in media using the drop technique (a) 0.1% (b) 0.25% (c) 0.5% 
 
(a) 
 
 
(c) 
 
 
(b) 
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Figure 5.13:  Shows drops of cells encapsulated within different concentrations of Puramatrix hydrogel (a) 
0.1% low magnification (b) 0.1% high magnification (c) 0.25% low magnification (d) high magnification (e) 
0.5% low magnification (f) high magnification. Note the difference in homogeneity, where the spheres are 
more homogenously distributed at low Puramatrix concentration. Cells are communicating with the hydrogel 
matrix and with other cells [black arrow]. 
 
(e) 
 
(f) 
(e) (f) 
 
(c) 
 
(d) 
(c) (d) 
 
(a) 
 
(b) 
(a) (b) 
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5.3.2 SEM morphology study:  
     Scanning electron microscopy was used to confirm and examine the formation of the 
nanofiber scaffold after the peptide self-assembly process.  
     The SEM images of Puramatrix hydrogel revealed the formation of nanofibers 
network which was more dense at higher concentrations [figure 5.14]. On the other hand, 
examination of cell/scaffold interaction revealed of the formation of cellular clusters in all 
concentrations but this was apparently increased in 0.1% [Figure 5.15] and 0.25% [Figure 
5.16]. Moreover, the SEM images revealed the formation of a thin layer of hydrogel that 
cells were interacting with and at a higher magnification; a cytoplasmic projections can 
be observed [Figure 5.15, and 5.18] 
     As seen in Figure 5.16 cellular spheroids were spotted on top of the nanofibers mesh 
while others managed to attach to the surface. In the case of 0.5% Puramatrix 
concentration few spheroids were noticed and they were interacting with a sheet of 
adhered cells [figure 5.17]. Few cell clusters were also noted in 0.1% Puramatrix with 
cells expanding across the surface of the tissue culture plastic [Figure 5.18].  
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Figure 5.14:  Shows SEM images of nanofiber networks formed after adding media to Puramatrix 
peptide.  Hydrogel nanofibers are more dense at higher peptide concentrations (a) 0.1% (b) 0.25% (c) 
0.5% (d) 1%  
 
(b) 
 
(a) 
 
(c) 
 
(d) 
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Figure 5.15:  Shows SEM images of rat calvarial cells grown on the surface of 0.1% 
Puramatrix hydrogel. Cells attached to the surface [black arrow] as well as cellular 
spheres [red arrow] can be seen, lamellipodia-like cell surface projections also are 
cleared [green arrow].   
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Figure 5.16:  Shows SEM images of rat calvarial cells grown on the surface of 0.25% Puramatrix 
hydrogel, cells attached to the surface of the hydrogel [black arrow] while others aggregated and 
formed spheres [red arrow]  
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Figure 5.17:  Shows SEM images of rat calvarial cells grown on the surface of 0.5% Puramatrix 
hydrogel, most of the cells adhered to the surface [black arrow] forming monolayer with few clusters [red 
arrow] 
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Figure 5.18:  Shows SEM images of rat calvarial cells grown on the surface of 1% Puramatrix hydrogel, 
few of the cells adhered to the surface of the scaffold [black arrow] and cellular clusters [red arrow] 
formed  
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5.3.3 Cell viability in the hydrogel environment: 
     Cell viability was quantified using a standard MTT assay after 24hr, 72hr, and 7days 
of cell culture.  
     In Figure 5.19 the viability of calvarial cells and after 24hr of encapsulation with 
0.25% of Puramatrix was significantly higher compared to 0.1% and 0.5%, with a 
significant increase in cells grown in normal media compared to osteogenic media.  
However, the viability was almost the same in both 0.1% and 0.5% with a non-significant 
small increase in cells grown under normal and osteogenic conditions, respectively.  In 
contrast, the viability of encapsulated MSCs in both 0.25% and 0.5% grown in osteogenic 
and normal media respectively was significantly higher [Figure 5.20].  
     At 72hr the viability of the calvarial cells increased significantly in 0.1% and 0.5% 
while it decreased in 0.25% in both normal and osteogenic media [Figure 5.21]. While the 
viability of MSCs in 0.1% and 0.25%, with a slight decrease in 0.5%, was evident 
[Figure5.22] 
     At 7 days the viability of calvarial cells in all Puramatrix concentrations decreased 
compared to cells at 72hr, with significant differences between groups [Figure 5.23]. 
Whereas with MSCs the viability increased again in 0.1% and 0.5% in both normal and 
osteogenic media but decreased in 0.25% in cells grown under osteogenic media but there 
was a slight increase in the viability of cells in 0.25% under normal conditions [Figure 
5.24].  
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P ≤ 0.05 
Figure 5.19 Graph shows the viability of encapsulated calvarial rat cells after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
* 
Figure 5.20 Graph shows the viability of encapsulated human MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
* 
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P ≤ 0.05 
Figure 5.22 Graph shows the viability of encapsulated human MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal 
media. 
 
* 
Figure 5.21 Graph shows the viability of encapsulated calvaria rat cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal 
media. 
 
* 
167 
 
 
Figure 5.23 Graph shows the viability of encapsulated calvarial rat cells at 7days, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal 
media. 
* 
Figure 5.24 Graph shows the viability of encapsulated human MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05.  No significance were seen compared to normal media, though there 
were significance between groups 
P ≤ 0.05 
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5.3.4 Alkaline phosphatase activity assay:  
     Osteogenic differentiation was evaluated by measuring ALP enzyme activity.  Figure 
5.25 compares ALP activity between the three Puramatrix concentrations where a 
significant high level of ALP was recorded in calvarial cells encapsulated within 0.25% 
Puramatrix compared to 0.1% and 0.5% after 24 hr. Similarly, a significant high level of 
ALP was recorded in MSCs encapsulated within 0.25% Puramatrix but only under 
osteogenic conditions, whereas it was slightly higher in MSCs encapsulated within 0.5% 
compared to 0.1% and 0.25% [Figure 5.26] 
     At 72hr ALP activity decreased in calvarial cells within 0.25% Puramatrix, while the 
level remained almost the same in 0.1% Puramatrix in normal media with a slight 
decrease in osteogenic media. Interestingly, the activity of calvarial ALP within 0.5% 
Puramatrix increased in both normal and osteogenic media [Figure 5.27]. On the other 
hand, the activity of ALP enzyme in MSCs encapsulated in 0.1% Puramatrix decreased 
and reached almost the same level in both normal and osteogenic media.  ALP activity 
also decreased in MSCs encapsulated with 0.25%, whereas in 0.5% the level of ALP 
increased under both normal and osteogenic conditions [Figure 5.28]. 
    ALP activity at 7 days increased again in both calvarial cells grown in normal and 
osteogenic media in 0.1% Puramatrix. There was a slight increase in ALP activity in 
calvarial cells within 0.25% Puramatrix in normal media, but conversely, under 
osteogenic conditions, a slight decrease in ALP activity was noted.  ALP activity 
decreased in calvarial cells encapsulated within 0.5% Puramatrix grown in normal media 
with a slight increase for those grown in osteogenic media [Figure 5.29]. However, ALP 
level in MSCs decreased slightly in MSCs encapsulated in 0.1% and 0.5% Puramatrix 
grown in normal media, while it increased under osteogenic conditions. In 0.25% 
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Puramatrix concentration the activity of the enzyme decreased in both normal and 
osteogenic media [figure 5.30].  
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P ≤ 0.05 
 
P ≤ 0.05 
Figure 5.25 Graph shows the alkaline phosphatase activity level of encapsulated calvarial cells 
after 24hr, the Data represents the mean ± standard error of the mean, n=9, a statistical 
significance was considered when P value ≤ 0.05. No significance detected compared to normal 
media, however there were between groups 
 
Figure 5.26 Graph shows the alkaline phosphatase activity level of encapsulated human MSCs 
after 24hr, the Data represents the mean ± standard error of the mean n=9, a statistical 
significance was considered when P value ≤ 0.05 where (*) indicates significance compared to 
normal media. 
 
* 
* 
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P ≤ 0.05 
Figure 5.27 Graph shows the alkaline phosphatase activity level of encapsulated calvarial cells at 
72hr, the Data represents the mean ± standard error of the mean n=9, a statistical significance was 
considered when P value ≤ 0.05. No significance was detected compared to normal media, though 
significance was detected between groups. 
 
Figure 5.28 Graph shows the alkaline phosphatase activity level of encapsulated human MSCs at 
72hr, the Data represents the mean ± standard error of the mean n=9, a statistical significance 
was considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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Figure 5.29 Graph shows the alkaline phosphatase activity level of encapsulated calvarial cells at 
7days, the data represents the mean ± standard error of the mean n=9, a statistical significance was 
considered when P value ≤ 0.05 No significance was detected compared to normal media, though 
significance was detected between groups. 
 
Figure 5.30 Graph shows the alkaline phosphatase activity level of encapsulated human MSCs at 
7days, the data represents the mean ± standard error of the mean, n=9, statistical significance was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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5.3.5 Modulation of gene expression by cells interacting with the 
hydrogel matrix: 
     The assessment of gene expression of osteogenic markers of cells encapsulated within 
the Puramatrix hydrogel was carried out using qRT-PCR.  
     After 24hr significant levels of ALP mRNA transcripts were detected in calvarial cells 
encapsulated within 0.5% and 0.25% grown in normal and osteogenic media respectively 
[Figure 31]. While a significant ALP expression was noted in MSCs encapsulated within 
0.25% and 0.5% under osteogenic conditions [Figure 5.32].  
     The expression of the enzyme increased significantly at 72hr in calvarial cells in 0.1% 
in normal and osteogenic media and in 0.25% osteogenic media [Figure 5.33]. However, 
ALP mRNA levels reached a high level in MSCs under osteogenic conditions in 0.5% 
Puramatrix while it significantly decreased in 0.25% both under osteogenic condition 
[Figure 5.34].  
     Interestingly ALP expression in calvarial cells was higher in normal media compared 
to osteogenic media, where it was significant in 0.25% Puramatrix. However, the 
expression decreased in 0.1% normal compared to 72hr [Figure 5.35]. On the contrary, 
ALP gene expression was significantly high in MSCs encapsulated with 0.5% Puramatrix 
[Figure 5.36].  
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Figure 5.31 ALP relative expression level in encapsulated calvarial cells after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
Figure 5.32 ALP relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
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Figure 5.33 ALP relative expression level in encapsulated calvarial cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.34 relative expression level in encapsulated MSCs at 72hr, the data represents 
the mean ± standard error of the mean n=9, a statistical significant was considered        
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
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Figure 5.35 ALP relative expression level in encapsulated calvarial cells at 7days, the Data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * * 
Figure 5.36 ALP relative expression level in encapsulated MSCs at 7days, the Data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal 
media. 
 
* * 
* 
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     After 24hr the level of Runx2 gene expression was higher in 0.1% and 0.25% 
Puramatrix under osteogenic conditions compared to normal, interestingly expression was 
higher in normal media at the higher Puramatrix concentration (0.5%). Though, overall 
calvarial cells in 0.5% normal media scored a significant high level [Figure 5.37]. In 
contrast, Runx2 expression in MSCs encapsulated in 0.25% and 0.5% were higher in 
osteogenic media, whereas in 0.1% a slight increase in gene expression in normal media 
compared to osteogenic media was observed [Figure 5.38]. 
     At 72hr Runx2 mRNA levels decreased in calvarial cells encapsulated in 0.5% 
Puramatrix while it increased in 0.1% and 0.25% in both normal and osteogenic media 
[Figure 5.39]. Whereas the expression increased significantly in MSCs encapsulated in 
0.1%, 0.25% and 0.5% under osteogenic conditions, with a higher expression in 0.25% 
noted [Figure 5.40].  
      At 7 days the expression decreased in calvarial cells encapsulated in 0.1% Puramatrix, 
but increased in 0.25 and 0.5% under normal conditions [Figure 5.41]. In MSCs the 
expression of Runx2 decreased in 0.25% while it increased in 0.5% grown in osteogenic 
media compared to 72hr, but overall Runx2 expression was more under osteogenic not 
normal media [Figure 5.42].  
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P ≤ 0.05 
Figure 5.37 RUNX 2 relative expression level in encapsulated calvarial cells after 24hr, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * 
* 
* 
* 
Figure 5.38 RUNX 2 relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
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Figure 5.39 RUNX 2 relative expression level in encapsulated calvarial cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.40 RUNX 2 relative expression level in encapsulated MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
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Figure 5.41 RUNX 2 relative expression level in encapsulated calvaria cells at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * 
Figure 5.42 RUNX 2 relative expression level in encapsulated MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
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     SP7 gene expression was significantly elevated in calvarial cells in 0.5% Puramatrix 
and osteogenic media after 24hr; the expression was also high in 0.25% Puramatrix and 
osteogenic media unlike 0.1% Puramatrix where it was higher in normal media [Figure 
5.43]. Similarly, in MSCs the expression was higher in 0.5% Puramatrix and osteogenic 
media [Figure 5.44].  
    At 72hr, the expression of SP7 increased significantly in calvaria cells encapsulated in 
all Puramatrix concentrations under osteogenic media conditions [Figure 5.45]. However, 
in MSCs the expression increased significantly in 0.1% and 0.25% in osteogenic media, 
increased in 0.5% in normal media only while it decreased in osteogenic media [figure 
4.46].  
     At 7 days, the expression of the gene decreased significantly in all Puramatrix 
concentrations, though the expression was higher in osteogenic media [Figure 5.47]. In 
contrast, SP7 expression increased in MSCs encapsulated within 0.5% Puramatrix grown 
in osteogenic media and decreased when grown in normal media. Conversely, the 
expression decreased in MSCs encapsulated in 0.2% and 0.1% grown in osteogenic media 
with a slight increase in those grown in normal media [Figure 4.48].  
182 
 
Figure 5.43 SP7 relative expression level in encapsulated calvarial cells after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.44 SP7 relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean, n=9, No statistical significant was 
detected. 
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Figure 5.45 SP7 relative expression level in encapsulated calvaria cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* * 
Figure 5.46 SP7 relative expression level in encapsulated MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal 
media. 
 
* 
* 
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Figure 5.47 SP7 relative expression level in encapsulated calvaria cells at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.48 SP7 relative expression level in encapsulated MSCs at 7days, the Data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
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     As seen in Figure 5.49 Cx43 was expressed significantly by calvarial cells embedded 
in 0.1% Puramatrix compared to 0.25% and 0.5%. Whereas in MSCs there was no 
significant differences in Cx43 expression in all three concentrations, though it was 
higher on cells grown in normal media [figure 5.50].  
     Cx43 expression at 72hr increased significantly in calvarial cells within 0.1% 
Puramatrix compared to 0.25% and 0.5%, this rise was in both normal and osteogenic 
media though it was more in former [figure 5.51]. In MSCs, Cx43 expression level was 
almost the same as 24hr under normal and osteogenic media in cells embedded in 0.1% 
and 0.5% respectively, while it increased significantly under normal and osteogenic 
media in 0.5% and 0.1% respectively. The expression also increased in 0.25% in both 
normal and osteogenic media [Figure 5.52]. 
     At 7days the expression in calvarial cells dropped significantly in 0.1% concentration 
under both normal and osteogenic media [Figure 5.53]. Interestingly, Cx43 increased 
significantly in cells within 0.25% grown in normal media while it decreased in 
osteogenic media [Figure 5.53]. On the other hand, MSCs in 0.1% and 0.25% Puramatrix 
showed Cx43 expression dropping in both normal and osteogenic media and in 0.5% 
Puramatrix  and normal media [figure 5.54]. However, a significant high expression level 
of Cx43 was noted in MSCs encapsulated in 0.5% Puramatrix grown in osteogenic media 
[figure 5.54].  
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Figure 5.50 CX43 relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was detected 
here 
 
Figure 5.49 CX43 relative expression level in encapsulated calvarial cells after 24hr, the Data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
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Figure 5.51 CX43 relative expression level in encapsulated calvarial cells at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when Pvalue ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.52 CX43 relative expression level in encapsulated MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * 
* 
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Figure 5.53 CX43 relative expression level in encapsulated calvarial cells at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.54 CX43 relative expression level in encapsulated MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
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      Calvaria cells ephrin B1 gene expression was significantly high in 0.1% and 0.25% 
under normal and osteogenic media respectively compared to other groups [figure 5.55]. 
But the expression was significantly higher in MSCs in 0.25% Puramatrix grown in 
osteogenic media [Figure 5.56].  
     Ephrin B1 expression continued to increase in 0.1% Puramatrix but in both normal and 
osteogenic media and in 0.25% under osteogenic conditions, whereas it decreased in 
0.25% Puramatrix under normal conditions [Figure 5.57]. It also decreased in calvarial 
cells within 0.5% Puramatrix in both normal and osteogenic media [Figure 5.57]. 
Although the expression of ephrin B1 increased in MSCs embedded in all three 
Puramatrix concentrations, the expression was significantly higher in 0.25% Puramatrix 
grown in osteogenic media [Figure 5.58].  
     At 7 days the expression of the gene dropped significantly in calvarial cells 
encapsulated within 0.1% Puramatrix in both normal and osteogenic media and 0.25% 
Puramatrix  and osteogenic media, while in 0.25% normal media the expression increased 
significantly [Figure 5.59]. In MSCs the expression dropped significantly in 0.25% 
Puramatrix and osteogenic media, conversely, it increased significantly in 0.5% under 
osteogenic conditions [Figure 5.60].  
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Figure 5.55 Ephrin B1 relative expression level in encapsulated calvarial cells after 24hr, the 
Data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
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Figure 5.56 Ephrin B1 relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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Figure 5.57 Ephrin B1 relative expression level in encapsulated calvarial cells at 72hr, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.58 Ephrin B1 relative expression level in encapsulated MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
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Figure 5.59 Ephrin B1 relative expression level in encapsulated calvarial cells at 7days, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * * 
Figure 5.60 Ephrin B1 relative expression level in encapsulated MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
193 
 
     A significantly high level of ephrin B2 mRNA transcripts was identified in calvarial 
cells encapsulated with 0.1% and 0.25% Puramatrix in normal and osteogenic media 
respectively [Figure 5.61]. Whereas the level of the gene was slightly more in 0.5% 
Puramatrix and normal media compared to osteogenic media [Figure 5.61]. On the other 
hand, the expression of the gene in MSCs was significantly high when encapsulated in 
0.5% Puramatrix and grown in osteogenic media [Figure 5.62].  
     At 72hr the gene expression increased significantly in calvarial cells encapsulated 
within 0.1% Puramatrix and normal and osteogenic media and it increased also in 0.25% 
osteogenic media [Figure 5.63]. Whilst in MSCs a significant difference in gene 
expression was noted, with an increase in the gene expression level recorded in both 0.1% 
and 0.25% Puramatrix in osteogenic media [Figure 5.64]. Though, the level of the gene 
decreased at 72hr in MSCs encapsulated within 0.5% Puramatrix and osteogenic media it 
was still higher than those in 0.5% Puramatrix and normal media [Figure 5.64].  
    At 7days the expression of ephrin B2 dropped in calvarial cells embedded in 0.1% and 
0.5% Puramatrix in normal and osteogenic media and in 0.25% Puramatrix in osteogenic 
media alone, but increased in 0.25% normal media [Figure 5.65].  Significant differences 
in the expression of the gene was recorded in MSCs, where it increased in 0.5% 
Puramatrix in normal and osteogenic media, and in 0.1% and 0.25% Puramatrix in normal 
media only but decreased in osteogenic media [Figure 5.66].  
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Figure 5.61 Ephrin B2 relative expression level in encapsulated calvarial cells after 24hr, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
* 
Figure 5.62 Ephrin B2 relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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Figure 5.63 Ephrin B2 relative expression level in encapsulated calvarial cells at 72hr, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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Figure 5.64 Ephrin B2 relative expression level in encapsulated MSCs at 72hr, the Data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
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Figure 5.65 Ephrin B2 relative expression level in encapsulated calvarial cells at 7days, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * * 
Figure 5.66 Ephrin B2 relative expression level in encapsulated MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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     Ephrin B4 gene expression in calvarial cells was high in 0.5% Puramatrix and normal 
media compared to 0.1% and 0.25% Puramatrix [Figure 5.67]. While in MSCs the 
expression was high in 0.25% Puramatrix and osteogenic media, and an almost equal 
expression level was recorded in 0.1% Puramatrix in normal and osteogenic media 
[Figure 5.68].  
     In contrast at 72 hrs, the level of the gene increased in calvarial cells within 0.1% 
Puramatrix plus normal and osteogenic media, and in 0.25% osteogenic media [Figure 
5.69]. While it decreased in 0.25% Puramatrix and normal media, and in 0.5% Puramatrix 
in both normal and osteogenic media [Figure 5.70]. The expression of ephrin B4 was 
significantly increased an MSCs encapsulated in 0.1%, 0.25% and 0.5% Puramatrix 
grown in osteogenic media and in 0.25% Puramatrix grown in normal media [Figure 
5.71].  
    At 7days ephrin B4 expression decreased significantly in calvarial cells within 0.1% 
Puramatrix plus normal and osteogenic media and in 0.25% Puramatrix and osteogenic 
media while it increased in 0.25% Puramatrix with normal media [Figure 5.72]. In MSCs 
the expression was also decreased in 0.1% Puramatrix with normal and osteogenic media, 
likewise in 0.25% Puramatrix in osteogenic media but increased under normal media 
[figure 5.73]. Whereas the expression increased significantly in 0.5% Puramatrix and 
normal media accompanied with a slight increase in osteogenic media [figure 5.73]. 
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Figure 5.67 Ephrin B4 relative expression level in encapsulated calvaria cells after 24hr, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
* 
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Figure 5.68 Ephrin B4 relative expression level in encapsulated MSCs after 24hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
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Figure 5.69 Ephrin B4 relative expression level in encapsulated calvarial cells at 72r, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered  
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
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Figure 5.70 Ephrin B4 relative expression level in encapsulated MSCs at 72hr, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was considered 
when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
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Figure 5.71 Ephrin B4 relative expression level in encapsulated calvarial cells at 7days, the 
data represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* * * 
Figure 5.72 Ephrin B4 relative expression level in encapsulated MSCs at 7days, the data 
represents the mean ± standard error of the mean n=9, a statistical significant was 
considered when P value ≤ 0.05 where (*) indicates significance compared to normal media. 
 
* 
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5.4 Discussion: 
     Hydrogel scaffolds have been the subject of intensive research interest as candidates in 
tissue engineering due to their similarities to natural ECM and their ability to be modified 
(Haycock 2011; El-Sherbiny and Yacoub 2013).  In the present study different 
concentrations of Puramatrix peptide hydrogel was tested assessed for their ability to 
influence osteogenesis and also alter the balance of cell-cell and cell-ECM interactions 
both in 2D and 3D.  
    Puramatrix is a self- assembling peptide that forms a hydrogel scaffold of nanofibers 
(McGrath, Novikova et al. 2010). According to the manufacturers, cells can be either 
seeded on top of the hydrogel surface or encapsulated within the hydrogel. In this study 
the first attempt was to seed cells on the surface of the Puramatrix. The results revealed 
the difficultly to obtain a durable layer of the scaffold which remained intact throughout 
the experimental period.  A significant contribution to this is undoubtedly the weak 
physical properties of the scaffold (Akiyama, Yamamoto-Fukuda et al. 2013) but 
mechanical tearing of the gel by the contractility of the cells cannot be ruled out. 
Consequently because of the hydrogel breaking some cells formed clusters while others 
adhered to what is likely to be the well plate surface (as viewed under phase contrast 
microscopy). However, when examined under scanning electron microscope a thin layer 
of biomaterial was seen where cells adhered to it. In this case it is likely that the stiffness 
of the underlying plastic contributes to reinforce the mechanical properties of the 
Puramatrix. In addition, SEM studies showed the formation of nanofibers mesh in all 
Puramatrix concentrations but this was denser at high concentrations. The structures of 
these fibres has previously been examined but by using atomic force microscopy where it 
was shown that at low Puramatrix concentration 0.1% and 0.25%, homogenous single and 
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bundle fibers were formed, while at higher concentrations a very dense nanofiber network 
was formed (Ortinau, Schmich et al. 2010).  
     An initial objective of the study was to examine and compare cells grown as a 
monolayer on the surface of a culture plate and on a Puramatrix hydrogel surface. 
However since it was difficult to obtain an intact layer of Puramatrix to which cells could 
unequivocally attach we had to focus our studies on cells encapsulated in Puramatrix. The 
work presented here found that with 0.1% Puramatrix the cell/hydrogel mixture was 
homogenous compared to 0.25% and 0.5%. Also, in all three concentrations cells were 
seen to communicate with each other as well as the surrounding material. This 
communication would likely allow cells to coordinate their activity through cell-cell 
interactions and secretion of paracrine molecules (Yoshida and Teramoto 2007).  
     The ability of Puramatrix to facilitate bone regeneration has previously been reported 
by (Misawa, Kobayashi et al. 2006). This is affected by cell viability and ability to 
produce osteogenic markers. In the current study when comparing the viability of the 
cells between rat calvaria cells and human MSCs it was found that at low concentration 
(0.1%) of Puramatrix and at high concentration (0.5%) the viability of MSCs was 
elevated. But when using 0.25% Puramatrix concentration the viability of calvaria cells 
was increased. These results suggest that undifferentiated cells respond differently to 
different concentrations of Puramatrix. This was confirmed by alkaline phosphatase 
enzyme activity measurement where it was greater in MSCs at 0.1% and 0.5% of the 
Puramatrix. However, when measuring the relative level expression of ALP it was found 
that calvarial cells grown in normal media expressed more ALP while it was higher in 
MSCs grown in osteogenic media in all concentrations. A possible explanation for this 
conflict between ALP colorimetric assay and qRt-PCR results could be due to the 
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sensitivity of the colorometric assay to different factors such as light (van Meerloo, 
Kaspers et al. 2011). However, this result has not previously been described.  
    On the other hand, effects of Puramatrix hydrogel concentration on osteogenic gene 
expression were examined. The results of the study showed that overall the expression of 
Runx2, Cx43, SP7, ephrinB1, ephrinB2, and ephrinB4 was greater in calvarial cells 
grown in normal media and in MSCs grown in osteogenic media. This suggested that, not 
only the concentration of Puramatrix may affect osteoblastogeneisis but also media 
composition as well. 
    The differential effects of Puramatrix concentration on cell activity could likely be 
mediated through the different mechanical properties of the gels.  Evidence suggests that 
the compliance of the interacting material will influence the biology of cells with for 
example MSCs differentiating to fat cells on a soft substrate whilst moving towards the 
osteoblast lineage on stiffer materials (Engler, Sen et al. 2006). In addition, our system 
could also influence the way in which cells interact with each other with cells within a 
high concentration of Puramatrix likely finding it more difficult to form cell-cell 
interactions in this environment. 
     In conclusion, Puramatrix hydrogel enhances cells osteogenesis in all three 
concentrations even though two cell lines behaved differently to different concentrations 
of hydrogel. Thus it is preferable to test the optimal concentration when using different 
cell lines.  
 
 
 
204 
 
 
Chapter 6: Final conclusions and future work 
     This study set out to address three aims: the first was to optimize the formation of 
spheroids in vitro and then assess spheroid viability and potential towards osteogenesis in 
comparison to cells grown in conventional monolayer [2D]; the second aim used rat 
calvarial cells and human mesenchymal stem cells and the spheroid culture system to 
examine cell/cell interactions and finally the last aim used RAD16-1 which is known 
commercially as Puramatrix™ and MAPTrix as a scaffold to create 3D environments for 
the cells and so manipulate the balance of cell-cell and cell-ECM interactions.  
     As tissue culture plastic is a topologically flat surface that poorly reproduces the 
complex architecture observed in vivo, 3D culture systems have been the subject of 
intense study (Page, Flood et al. 2013). Spheroid cells aggregates are the most widely 
used 3D culture system (Mueller-Reichert 2010).  Since spontaneous cell aggregation 
occurs only in a few cancerous cell lines 3D culture systems ranging from simple to a 
more complex methods have been developed for other cell types (Page, Flood et al. 
2013).  In work presented here, the efficiency of spheroid formation was investigated 
using different simple approaches and different cells densities for culturing cells in 3D. 
The results concluded that with the cell types investigated in these studies that using an 
anti-adhesive material, PolyHEMA to prevent cells adherence was as an effective simple 
and cost-efficient method for the production of spheroids.  However, the limitation of this 
method is that the size of the spheres initially formed is less controllable, athough the size 
and number will change anyway over time. It has been suggested that neither a too low or 
a too high cell density should be used in initially setting up the cultures as the resulting 
spheroids may exhibit poor intercellular communication and transport limitation 
respectively (Goldstein 2001). The findings of the work presented here support the idea of 
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using high cell density for the production of spheroids as previously described 
(Langenbach, Berr et al. 2011). Moreover,  high alkaline phosphatase activity and more 
mineralization was observed in dense cultures (Goldstein 2001).  
     In addition, the viability of the cells was measured using MTT assay which seemed a 
suitable choice during the research. However, other work suggests that measuring total 
DNA is the most reliable method in 3D culture and when seeding at high cell density (Ng, 
Leong et al. 2005). Therefore the limitation of various methods available for measuring 
cells proliferation should be taking in to consideration (Ng, Leong et al. 2005).  Our 
rationale for using MTT was to assess only viable cells in the culture system. 
     Osteoblastogenesis and mesenchymal stem cell differentiation was investigated and 
contrasted between traditional tissue culture and in 3D spheroids. It was reported 
previously that gene expression by cells grown in 3D correlates more closely with the in 
vivo scenario in comparison to 2D cell culture (Sivaraman, Leach et al. 2005). 
Furthermore, the ability of spheroids to differentiate to osteogenic tissue spontaneously 
has been previously reported using human unrestricted somatic stem cells (Langenbach, 
Berr et al. 2011). The results of this study revealed that alkaline phosphatase activity 
appeared more elevated in 2D cultures compared to 3D.  However, it was noted that there 
were contrasting results between the two types of cells with expression of osteogenic 
genes; higher when MSCs were grown in osteogenic media while with calvarial 
osteoblasts significant expression was also observed when grown in normal media.  It is 
therefore important to consider the phenotype of the cells, their environment and the 
chemical cues given to the cells when interpreting these findings.  The rat osteoblast 
cultures are enriched pools of osteogenic cells that are committed to that lineage while the 
mesenchymal stem cell populations are heterogeneous and contain cells that are 
multipotent as well as some that have begun to make fate decisions.  The mechanical 
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environment and cytoskeletal tension is a strong regulator of differentiation and therefore 
it is of little surprise that rat osteoblasts grown on stiff tissue culture plastic need little 
encouragement to further differentiate. Whilst for MSCs they would be significantly 
responsive to the osteogenic media and find the 3D spheroid environment more analogous 
to the soft marrow pericellular environment, with not only matrix, but also direct contact 
from other cells influencing their activity. 
    Because of the potential regulatory cues delivered by cell-cell interactions such as gap 
junctions, experiments were performed to determine their role.  Cx43 in bone has been 
widely studied where it was found that it releases bone modulators affecting bone 
remodelling under mechanical stimuli (Batra and Jiang 2012).  Also Cx43 is required for 
the anabolic effect of  Parathyroid hormone [PTH] (Loiselle, Paul et al. 2013). Where 
osteoblasts lacking Cx43 do not respond to PTH causing decrease in bone mineral 
content, they exhibit altered response to mechanical forces  (Plotkin and Bellido 2013). 
Moreover, previous studies note an up-regulation of Cx43 during fracture healing 
(Loiselle, Paul et al. 2013).  The results of the experiments presented here reveal that 
Cx43 localization in 2D was different under normal conditions compared to osteogenic 
media with its redistribution to the cell surface and formation of cell-cell plaques as the 
cells differentiate.  But in 3D culture it was difficult to study Cx43 localization by 
microscopy, which is considered one of the challenges accompanied with the use of 3D 
culture systems (Mueller-Reichert 2010), however puntate staining could be observed that 
may have been of increased intensity at the cell surface.  There was certainly evidence of 
increased immunoreactivity in rat spheroids compared to the ones derived from human 
MSCs.  This was supported by the qRT-PCR data which showed elevated levels of 
transcripts for Cx43 in rat cells compared to human MSCs.  Trends for the expression of 
Cx43, Ephrin B1 and Ephrin B2 were similar for each cell type in a given condition 
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showing that regulation of these proteins that are responsible for cell-cell interactions is 
likely to be coordinated.  Interestingly Cx43 expression seemed to increase over the 7 
days in human MSCs cultured in 3D perhaps reflecting the formation of durable gap 
junction structures.    
 
     Finally, identifying an optimal scaffold  to aid tissue repair in regenerative medicine 
treatment strategies is a key challenge (Chatterjee, Lin-Gibson et al. 2010). Spheroids 
provide a way of delivering large numbers of viable cells in a controlled environment to 
help facilitate regeneration of diseased or damaged tissues.  Experiments were therefore 
performed to investigate if spheroids could be reinforced with biomolecular scaffolds and 
investigate how this affects cell function. So, mainly we aimed to examine two types of 
hydrogel MAPTrix and Puramatrix.  However due to the poor mechanical properties of 
MAPTrix, Puramatrix only was used in this study.  Puramatrix is a sequence of peptide 
that builds a hydrogel scaffold of nano-fibers based on bottom-up assembly (Ye, Zhang et 
al. 2008). An initial attempt to seed cells directly on the surface of Puramatrix and cell 
drop technique was used to create 3D aggregates. In this study, three concentration of 
Puramatrix was used. The results showed that Puramatrix enhanced cells osteogenesis 
overall however, calvarial cell viability in 0.25% of Puramatrix was high compared to 
other concentrations, while in MSCs the viability was greater in 0.5% Puramatrix. 
Similarly, alkaline phosphatase activity in calvarial cells was high in 0.25% whereas 
MSCs favoured 0.5% of Puramatrix. It is interesting that cell osteogenesis was enhanced 
in Puramatrix hydrogel, although, previous studies reported that osteoblasts favour stiffer 
materials (McCauley and Somerman 2012; Eyckmans and Chen 2014).   
     Recently Pannaxins gap junction have interested researchers where studies have 
shown that osteoblastic cells express pannexins 1 and 3, the former is believed to effect 
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cell mechanotransduction whereas the latter is a Runx2 signalling target (Plotkin and 
Bellido 2013).  Moreover, these junctions drive cells aggregation through a signalling 
cascade which remodels actin cytoskeleton (Bao, Lai et al. 2012). In addition, it was 
found that Pannexin 1 determines the degree of compaction of the spheroids (Fennema, 
Rivron et al. 2013). Therefore, a further study with more focus on Pannaxins role on cells 
aggregation and their role on osteogenesis is suggested.  
    Overall, spheroids form a more complex cell/cell and cell/ECM interaction, however, 
there is still doubt whether spheroids [3D] is significantly closer to cells in vivo than cells 
in thin monolayer [2D] because of the challenges associated with culturing spheroids 
(Achilli, Meyer et al. 2012). For example, it is difficult to control spheroids in culture, 
microscopy and assays techniques to analyse spheroids are also difficult (Achilli, Meyer 
et al. 2012) and a high-throughput confocal structural analysis of 3D cultures has not yet 
been established (Fennema, Rivron et al. 2013).  
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Appendix A: Dulbecco's Modified Eagle Medium (DMEM) High glucose Media 
Formulations 
  
Components Molecular Weight Concentration (mg/L) mM 
Amino Acids 
Glycine 75 30 0.4 
L-Arginine hydrochloride 211 84 0.398 
L-Cystine 2HCl 313 63 0.201 
L-Glutamine 146 580 3.97 
L-Histidine hydrochloride-H2O 210 42 0.2 
L-Isoleucine 131 105 0.802 
L-Leucine 131 105 0.802 
L-Lysine hydrochloride 183 146 0.798 
L-Methionine 149 30 0.201 
L-Phenylalanine 165 66 0.4 
L-Serine 105 42 0.4 
L-Threonine 119 95 0.798 
L-Tryptophan 204 16 0.0784 
L-Tyrosine 181 72 0.398 
L-Valine 117 94 0.803 
Vitamins 
Choline chloride 140 4 0.0286 
D-Calcium pantothenate 477 4 0.00839 
Folic Acid 441 4 0.00907 
Niacinamide 122 4 0.0328 
Pyridoxine hydrochloride 204 4 0.0196 
Riboflavin 376 0.4 0.00106 
Thiamine hydrochloride 337 4 0.0119 
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i-Inositol 180 7.2 0.04 
Inorganic Salts 
Calcium Chloride (CaCl2-2H2O) 147 264 1.8 
Ferric Nitrate (Fe(NO3)3"9H2O) 404 0.1 0.000248 
Magnesium Sulfate (MgSO4-
7H2O) 
246 200 0.813 
Potassium Chloride (KCl) 75 400 5.33 
Sodium Bicarbonate (NaHCO3) 84 3700 44.05 
Sodium Chloride (NaCl) 58 6400 110.34 
Sodium Phosphate monobasic 
(NaH2PO4-2H2O) 
154 141 0.916 
Other Components 
D-Glucose (Dextrose) 180 4500 25 
Phenol Red 376.4 15 0.0399 
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Appendix B: Dulbecco's Modified Eagle Medium (DMEM) Low glucose Media 
Formulations 
Components [g/L] Concentration  
Inorganic Salts  
CaCl2 0.2 
Fe(NO3)3 • 9H2O 0.0001 
MgSO4 0.09767 
KCl 0.4 
NaHCO3 3.7 
NaCl 6.4 
NaH2PO4 0.109 
Amino Acids  
L-Alanyl-L-Glutamine - 
L-Arginine • HCl 0.084 
L-Cysteine • 2HCl 0.0626 
L-Glutamine - 
Glycine 0.03 
L-Histidine • HCl • H2O 0.042 
L-Isoleucine 0.105 
L-Leucine 0.105 
L-Lysine • HCl 0.146 
L-Methionine 0.03 
L-Phenylalanine 0.066 
L-Serine 0.042 
L-Threonine 0.095 
L-Tryptophan 0.016 
L-Tyrosine • 2Na • 2H2O 0.10379 
L-Valine 0.094 
Vitamins  
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Choline Chloride 0.004 
Folic Acid 0.004 
myo-Inositol 0.0072 
Niacinamide 0.004 
D-Pantothenic Acid • ½Ca 0.004 
Pyridoxal • HCl - 
Pyridoxine • HCl 0.004 
Riboflavin 0.0004 
Thiamine • HCl 0.004 
Other  
D-Glucose 1.0 
HEPES - 
Phenol Red • Na 0.0159 
Pyruvic Acid • Na 0.11 
ADD  
Glucose - 
L-Glutamine 0.584 
NaHCO3 - 
 
 
 
 
 
